TLK2
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A6NMY6 | S127 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | AQyDAsELKAsMKGLGtDEDsLIEIICsRtNQELQEINRVy |
| O00115 | S57 | Sugiyama | DNASE2 DNASE2A DNL2 | ALRGSGEAAQRGLQYKyLDEssGGWRDGRALINsPEGAVGR |
| O00115 | S58 | Sugiyama | DNASE2 DNASE2A DNL2 | LRGSGEAAQRGLQYKyLDEssGGWRDGRALINsPEGAVGRS |
| O00170 | T48 | Sugiyama | AIP XAP2 | FQDGTKATFHYRtLHsDDEGtVLDDsRARGKPMELIIGKKF |
| O00273 | S90 | Sugiyama | DFFA DFF1 DFF45 H13 | VDDDDYFLCLPSNTKFVALAsNEKWAYNNSDGGTAWIsQEs |
| O00592 | T556 | Sugiyama | PODXL PCLP PCLP1 | DsWIVPLDNLTKDDLDEEEDtHL__________________ |
| O15212 | S53 | Sugiyama | PFDN6 HKE2 PFD6 | LEAQLtENNIVKEELALLDGsNVVFKLLGPVLVKQELGEAR |
| O43290 | T430 | Sugiyama | SART1 | RKKEKEVVVRADDLLPLGDQtQDGDFGsRLRGRGRRRVsEV |
| O43615 | S193 | Sugiyama | TIMM44 MIMT44 TIM44 | TAAFRALsQGVEsVKKEIDDsVLGQtGPyRRPQRLRKRTEF |
| O43719 | S702 | Sugiyama | HTATSF1 | EDADGKEVEDADEKLFEDDDsNEKLFDEEEDssEKLFDDsD |
| O43719 | S713 | Sugiyama | HTATSF1 | DEKLFEDDDsNEKLFDEEEDssEKLFDDsDERGTLGGFGSV |
| O43852 | T177 | Sugiyama | CALU | ERRFKMADKDGDLIATKEEFtAFLHPEEyDyMKDIVVQEtM |
| O43852 | T196 | Sugiyama | CALU | FtAFLHPEEyDyMKDIVVQEtMEDIDKNADGFIDLEEyIGD |
| O43852 | T254 | Sugiyama | CALU | REQFVEFRDKNRDGKMDKEEtKDWILPsDyDHAEAEARHLV |
| O60231 | S106 | Sugiyama | DHX16 DBP2 DDX16 KIAA0577 PRP2 | EARALLEKNRSYRLLEDsEEssEEtVsRAGsSLQKKRKKRK |
| O60343 | S304 | Sugiyama | TBC1D4 AS160 KIAA0603 | ASQPALTSSRVCFPERILEDsGFDEQQEFRsRCssVTGVQR |
| O60610 | S542 | Sugiyama | DIAPH1 DIAP1 | ALHSEKQQIATEKQDLEAEVsQLtGEVAKLTKELEDAKKEM |
| O60610 | S793 | Sugiyama | DIAPH1 DIAP1 | YKPEVQLRRPNWSKLVAEDLsQDCFWtKVKEDRFENNELFA |
| O75533 | T316 | Sugiyama | SF3B1 SAP155 | tPKtERDtPGHGsGWAEtPRtDRGGDsIGEtPtPGAsKRKs |
| O75534 | S782 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | LDDAsAPRLMVLRQPRGPDNsMGFGAERKIRQAGVID____ |
| O75821 | T206 | Sugiyama | EIF3G EIF3S4 | LGLstGEKEKLPGELEPVQAtQNKtGKYVPPsLRDGAsRRG |
| O75934 | T40 | Sugiyama | BCAS2 DAM1 | DQGYEAPGVREAAAALVEEEtRRYRPTKNYLSYLTAPDYSA |
| O94888 | S288 | Sugiyama | UBXN7 KIAA0794 UBXD7 | sssPPKKCARsEsLIDAsEDsQLEAAIRASLQETHFDstQT |
| O95218 | S181 | Sugiyama | ZRANB2 ZIS ZNF265 | DEDLsKyKLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRR |
| O95433 | T20 | Sugiyama | AHSA1 C14orf3 HSPC322 | _MAKWGEGDPRWIVEERADAtNVNNWHWtERDASNWSTDKL |
| O95551 | T92 | Sugiyama | TDP2 EAP2 TTRAP AD-022 | ERRPETISEPKTyVDLtNEEtTDsttsKISPSEDTQQENGS |
| O95816 | S208 | Sugiyama | BAG2 | IKLLEHSKGAGSKTLQQNAEsRFN_________________ |
| P00338 | S105 | Sugiyama | LDHA PIG19 | VTANsKLVIItAGARQQEGEsRLNLVQRNVNIFKFIIPNVV |
| P02545 | S463 | Sugiyama | LMNA LMN1 | EEVDEEGKFVRLRNKsNEDQsMGNWQIKRQNGDDPLLtYRF |
| P04040 | T441 | Sugiyama | CAT | HSIQYSGEVRRFNtANDDNVtQVRAFyVNVLNEEQRKRLCE |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | T123 | Sugiyama | ALDOA ALDA | GVVGIKVDKGVVPLAGtNGEtttQGLDGLsERCAQYKKDGA |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04083 | T169 | Sugiyama | ANXA1 ANX1 LPC1 | IRDINRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRs |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05198 | T284 | Sugiyama | EIF2S1 EIF2A | EKRGVFNVQMEPKVVtDtDEtELARQMERLERENAEVDGDD |
| P05362 | S88 | Sugiyama | ICAM1 | ELLLPGNNRKVYELSNVQEDsQPMCYSNCPDGQSTAKTFLT |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05455 | S325 | Sugiyama | SSB | VLEGEVEKEALKKIIEDQQEsLNKWKSKGRRFKGKGKGNKA |
| P06733 | S40 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | VEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGK |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P07195 | S106 | Sugiyama | LDHB | VtANSKIVVVtAGVRQQEGEsRLNLVQRNVNVFKFIIPQIV |
| P07195 | T18 | Sugiyama | LDHB | ___MATLKEKLIAPVAEEEAtVPNNKITVVGVGQVGMACAI |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07237 | T462 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | tLKFFPAsADRtVIDyNGERtLDGFKKFLESGGQDGAGDDD |
| P07355 | S127 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | AQyDAsELKAsMKGLGtDEDsLIEIICsRtNQELQEINRVy |
| P07437 | S75 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| P07437 | T55 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPGtMDs |
| P07602 | T26 | Sugiyama | PSAP GLBA SAP1 | LLASLLGAALAGPVLGLKECtRGsAVWCQNVKTASDCGAVK |
| P07737 | S30 | Sugiyama | PFN1 | NLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEVGV |
| P07737 | S85 | Sugiyama | PFN1 | tLGGQKCsVIRDsLLQDGEFsMDLRtKstGGAPTFNVtVtK |
| P07814 | T745 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | KNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAVQGDVVR |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P07900 | S641 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DNstMGyMAAKKHLEINPDHsIIEtLRQKAEADKNDKSVKD |
| P07900 | T305 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IDQEELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLA |
| P08238 | S460 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQ |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | T297 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IDQEELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLA |
| P08238 | T467 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | NRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyIt |
| P08238 | Y457 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMK |
| P08621 | S410 | Sugiyama | SNRNP70 RNPU1Z RPU1 SNRP70 U1AP1 | DEARGGGGGQDNGLEGLGNDsRDMYMESEGGDGYLAPENGY |
| P08708 | S89 | Sugiyama | RPS17 RPS17L | ISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKEMLKLL |
| P08708 | Y84 | Sugiyama | RPS17 RPS17L | GPVRGISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKE |
| P08758 | S37 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | ERADAEtLRKAMKGLGtDEEsILtLLtsRsNAQRQEISAAF |
| P08758 | T40 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | DAEtLRKAMKGLGtDEEsILtLLtsRsNAQRQEISAAFKTL |
| P09104 | S40 | Sugiyama | ENO2 | VEVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGK |
| P09382 | S63 | Sugiyama | LGALS1 | CLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVFPFQPG |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P0DPH7 | S48 | Sugiyama | TUBA3C TUBA2 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P0DPH7 | T51 | Sugiyama | TUBA3C TUBA2 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P0DPH7 | T73 | Sugiyama | TUBA3C TUBA2 | FsEtGAGKHVPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLI |
| P0DPH7 | T80 | Sugiyama | TUBA3C TUBA2 | KHVPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLItGKEDAA |
| P0DPH7 | T82 | Sugiyama | TUBA3C TUBA2 | VPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLItGKEDAANN |
| P0DPH7 | Y83 | Sugiyama | TUBA3C TUBA2 | PRAVFVDLEPtVVDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P10109 | S148 | Sugiyama | FDX1 ADX | DAITDEENDMLDLAyGLTDRsRLGCQICLTKsMDNMTVRVP |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T37 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P11387 | S10 | Sugiyama | TOP1 | ___________MsGDHLHNDsQIEADFRLNDsHKHKDKHKD |
| P13073 | S34 | Sugiyama | COX4I1 COX4 | AISTSVCVRAHESVVKsEDFsLPAyMDRRDHPLPEVAHVKH |
| P13639 | S587 | Sugiyama | EEF2 EF2 | CIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKAR |
| P13667 | T380 | Sugiyama | PDIA4 ERP70 ERP72 | PEKFQSKYEPRSHMMDVQGstQDsAIKDFVLKyALPLVGHR |
| P13929 | S40 | Sugiyama | ENO3 | VEVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGK |
| P14314 | T115 | Sugiyama | PRKCSH G19P1 | GVCDCCDGtDEyNsGVICENtCKEKGRKEREsLQQMAEVtR |
| P14314 | T134 | Sugiyama | PRKCSH G19P1 | NtCKEKGRKEREsLQQMAEVtREGFRLKKILIEDWKKAREE |
| P14314 | T78 | Sugiyama | PRKCSH G19P1 | CKDGSDEPGTAACPNGSFHCtNtGyKPLyIPSNRVNDGVCD |
| P14625 | T522 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | NRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMA |
| P14649 | S87 | Sugiyama | MYL6B MLC1SA | EEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVLK |
| P15311 | S539 | Sugiyama | EZR VIL2 | TEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHNENMR |
| P15531 | S120 | Sugiyama | NME1 NDPKA NM23 | KPGtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELV |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P17066 | T228 | Sugiyama | HSPA6 HSP70B' | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P19338 | S619 | Sugiyama | NCL | RIVTDRETGssKGFGFVDFNsEEDAKAAKEAMEDGEIDGNK |
| P19338 | T583 | Sugiyama | NCL | sPNARSQPSKTLFVKGLsEDttEEtLKEsFDGsVRARIVTD |
| P20042 | T31 | Sugiyama | EIF2S2 EIF2B | tMsKKKKKKKKPFMLDEEGDtQtEEtQPsETKEVEPEPtED |
| P20042 | T36 | Sugiyama | EIF2S2 EIF2B | KKKKKKPFMLDEEGDtQtEEtQPsETKEVEPEPtEDKDLEA |
| P20810 | T334 | Sugiyama | CAST | EVDEAKAKEEKLEKCGEDDEtIPsEyRLKPATDKDGKPLLP |
| P23526 | T157 | Sugiyama | AHCY SAHH | NLIHTKYPQLLPGIRGIsEEtTTGVHNLyKMMANGILKVPA |
| P23588 | S207 | Sugiyama | EIF4B | DRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDR |
| P25786 | T11 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | __________MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQ |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26639 | S522 | Sugiyama | TARS1 TARS | PEKFLGDIEVWDQAEKQLENsLNEFGEKWELNsGDGAFyGP |
| P26639 | T700 | Sugiyama | TARS1 TARS | EKISGTVNIRTRDNKVHGERtIsEtIERLQQLKEFRSKQAE |
| P27348 | S145 | Sugiyama | YWHAQ | YFRyLAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHP |
| P27797 | S214 | Sugiyama | CALR CRTC | GsLEDDWDFLPPKKIKDPDAsKPEDWDERAKIDDPtDsKPE |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P27816 | S1151 | Sugiyama | MAP4 | LSGGGDQREAQtLDsQIQEtsI___________________ |
| P27816 | S643 | Sugiyama | MAP4 | IsPEtVTGtGKKCsLPAEEDsVLEKLGERKPCNsQPSELSS |
| P27816 | T57 | Sugiyama | MAP4 | VVGETVGKTDyIPLLDVDEKtGNsESKKKPCsEtsQIEDtP |
| P28340 | S1042 | Sugiyama | POLD1 POLD | QGAVCEFCQPRESELYQKEVsHLNALEERFSRLWTQCQRCQ |
| P29083 | S284 | Sugiyama | GTF2E1 TF2E1 | LHRAsLEGKSAKERPIWLREstVQGAYGsEDMKEGGIDMDA |
| P29083 | T285 | Sugiyama | GTF2E1 TF2E1 | HRAsLEGKSAKERPIWLREstVQGAYGsEDMKEGGIDMDAF |
| P29401 | T342 | Sugiyama | TKT | GQALAKLGHAsDRIIALDGDtKNstFsEIFKKEHPDRFIEC |
| P29692 | S37 | Sugiyama | EEF1D EF1D | KYDDAERRFyEQMNGPVAGAsRQENGAsVILRDIARARENI |
| P30101 | S343 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | IPVVAIRTAKGEKFVMQEEFsRDGKALERFLQDyFDGNLKR |
| P30101 | T485 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKKKKAQEDL |
| P31327 | T54 | Sugiyama | CPS1 | PGIRLLSVKAQtAHIVLEDGtKMKGYSFGHPSSVAGEVVFN |
| P34741 | T128 | Sugiyama | SDC2 HSPG1 | DKEKVHLSDSERKMDPAEEDtNVyTEKHSDSLFKRTEVLAA |
| P34931 | T228 | Sugiyama | HSPA1L | DVSILTIDDGIFEVKAtAGDtHLGGEDFDNRLVsHFVEEFK |
| P34931 | T39 | Sugiyama | HSPA1L | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P34932 | S414 | Sugiyama | HSPA4 APG2 HSPH2 | ITDVVPYPISLRWNsPAEEGssDCEVFSKNHAAPFSKVLTF |
| P35269 | S217 | Sugiyama | GTF2F1 RAP74 | RGRRKASELRIHDLEDDLEMssDAsDAsGEEGGRVPKAKKK |
| P35579 | S1308 | Sugiyama | MYH9 | LLsQsDSKSSKLTKDFsALEsQLQDtQELLQEENRQKLsLs |
| P35579 | S1915 | Sugiyama | MYH9 | KLQRELEDAtEtADAMNREVssLKNKLRRGDLPFVVPRRMA |
| P35579 | T1151 | Sugiyama | MYH9 | EKQKRDLGEELEALKtELEDtLDstAAQQELRSKREQEVNI |
| P35579 | T1904 | Sugiyama | MYH9 | EEAQRANAsRRKLQRELEDAtEtADAMNREVssLKNKLRRG |
| P35579 | T1906 | Sugiyama | MYH9 | AQRANAsRRKLQRELEDAtEtADAMNREVssLKNKLRRGDL |
| P35580 | T1718 | Sugiyama | MYH10 | SsERARRHAEQERDELADEItNSASGKSALLDEKRRLEARI |
| P35637 | S462 | Sugiyama | FUS TLS | NECNQCKAPKPDGPGGGPGGsHMGGNyGDDRRGGRGGYDRG |
| P35659 | S231 | Sugiyama | DEK | SGMARKAKRTKCPEILsDEsssDEDEKKNKEEssDDEDKEs |
| P35659 | S306 | Sugiyama | DEK | DSSTTKKNQNSSKKEsEsEDssDDEPLIKKLKKPPTDEELK |
| P36578 | S87 | Sugiyama | RPL4 RPL1 | WGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAPTKT |
| P36578 | T84 | Sugiyama | RPL4 RPL1 | AEsWGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAP |
| P36954 | S73 | Sugiyama | POLR2I | IyVNKITHEVDELtQIIADVsQDPTLPRTEDHPCQKCGHKE |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P38398 | S1271 | Sugiyama | BRCA1 RNF53 | CLsKNTEENLLSLKNsLNDCsNQVILAKAsQEHHLsEETKC |
| P38646 | T111 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VAFtADGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDP |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39687 | S27 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | IHLELRNRtPsDVKELVLDNsRsNEGKLEGLTDEFEELEFL |
| P39687 | T126 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | IEPLKKLENLKsLDLFNCEVtNLNDyRENVFKLLPQLtyLD |
| P39687 | T143 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | CEVtNLNDyRENVFKLLPQLtyLDGyDRDDKEAPDsDAEGY |
| P41091 | T21 | Sugiyama | EIF2S3 EIF2G | MAGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAt |
| P43243 | S234 | Sugiyama | MATR3 KIAA0723 | yDRMDyEDDRLRDGERCRDDsFFGEtsHNyHKFDsEyERMG |
| P43243 | T239 | Sugiyama | MATR3 KIAA0723 | yEDDRLRDGERCRDDsFFGEtsHNyHKFDsEyERMGRGPGP |
| P43243 | Y243 | Sugiyama | MATR3 KIAA0723 | RLRDGERCRDDsFFGEtsHNyHKFDsEyERMGRGPGPLQER |
| P46013 | T1967 | Sugiyama | MKI67 | KAKALEDLAGFKELFQtPGHtEEsMtDDKITEVsCKsPQPD |
| P46013 | T1972 | Sugiyama | MKI67 | EDLAGFKELFQtPGHtEEsMtDDKITEVsCKsPQPDPVKtP |
| P46013 | T2094 | Sugiyama | MKI67 | EDLAGFKELFQtPDHTEESttDDKTTKIACKsPPPEsMDtP |
| P46937 | S382 | Sugiyama | YAP1 YAP65 | QNPVssPGMsQELRTMttNssDPFLNsGtyHsRDEstDsGL |
| P46937 | T379 | Sugiyama | YAP1 YAP65 | GGtQNPVssPGMsQELRTMttNssDPFLNsGtyHsRDEstD |
| P46940 | S1448 | Sugiyama | IQGAP1 KIAA0051 | AIRDAKTPDKMKKsKsVKEDsNLtLQEKKEKIQTGLKKLTE |
| P46940 | T1451 | Sugiyama | IQGAP1 KIAA0051 | DAKTPDKMKKsKsVKEDsNLtLQEKKEKIQTGLKKLTELGt |
| P48741 | T228 | Sugiyama | HSPA7 HSP70B | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P54105 | S42 | Sugiyama | CLNS1A CLCI ICLN | DTEAVLNGKGLGtGtLyIAEsRLSWLDGsGLGFSLEYPTIS |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | T38 | Sugiyama | HSPA2 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P56385 | S66 | Sugiyama | ATP5ME ATP5I ATP5K | EEKKKQDELKRIARELAEDDsILK_________________ |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60660 | S30 | Sugiyama | MYL6 | AEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVLK |
| P60660 | T103 | Sugiyama | MYL6 | QGtyEDyVEGLRVFDKEGNGtVMGAEIRHVLVtLGEKMTEE |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61353 | T33 | Sugiyama | RPL27 | VLAGRYSGRKAVIVKNIDDGtsDRPysHALVAGIDRyPRKV |
| P61604 | S21 | Sugiyama | HSPE1 | MAGQAFRKFLPLFDRVLVERsAAETVTKGGIMLPEKSQGKV |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | S38 | Sugiyama | YWHAG | ERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKNVVGARRS |
| P61981 | T31 | Sugiyama | YWHAG | ARLAEQAERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62495 | S295 | Sugiyama | ETF1 ERF1 RF1 SUP45L1 | LSNVKFIQEKKLIGRyFDEIsQDtGKyCFGVEDTLKALEMG |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62854 | S57 | Sugiyama | RPS26 | KKFVIRNIVEAAAVRDIsEAsVFDAyVLPKLYVKLHYCVSC |
| P62857 | S39 | Sugiyama | RPS28 | GRtGsQGQCtQVRVEFMDDtsRsIIRNVKGPVREGDVLtLL |
| P62857 | T38 | Sugiyama | RPS28 | LGRtGsQGQCtQVRVEFMDDtsRsIIRNVKGPVREGDVLtL |
| P62857 | T57 | Sugiyama | RPS28 | DtsRsIIRNVKGPVREGDVLtLLEsEREARRLR________ |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63220 | S31 | Sugiyama | RPS21 | LYVPRKCSASNRIIGAKDHAsIQMNVAEVDKVTGRFNGQFK |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | S48 | Sugiyama | TUBA1B | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P68363 | T51 | Sugiyama | TUBA1B | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T80 | Sugiyama | TUBA1B | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| P78371 | T474 | Sugiyama | CCT2 99D8.1 CCTB | AGYDSADLVAQLRAAHsEGNttAGLDMREGTIGDMAILGIT |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| Q01082 | S2115 | Sugiyama | SPTBN1 SPTB2 | ERKRRPPsPEPstKVsEEAEsQQQWDtsKGEQVsQNGLPAE |
| Q01082 | S35 | Sugiyama | SPTBN1 SPTB2 | QQQYSDVNNRWDVDDWDNENsSARLFERSRIKALADEREAV |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01105 | T126 | Sugiyama | SET | SALLGEEDEEALHYLTRVEVtEFEDIKsGyRIDFyFDENPy |
| Q02952 | T597 | Sugiyama | AKAP12 AKAP250 | tCLEKGLAEVQQDGEAEEGAtsDGEKKREGVtPWAsFKKMV |
| Q05682 | S129 | Sugiyama | CALD1 CAD CDM | KRLQEALERQKEFDPtItDAsLsLPsRRMQNDTAENETTEK |
| Q07021 | S210 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | EDEVGQEDEAEsDIFsIREVsFQstGESEWKDTNYTLNTDS |
| Q07157 | S1064 | Sugiyama | TJP1 ZO1 | PYVEKQAsRDLEQPtyRyEsssytDQFsRNYEHRLRYEDRV |
| Q08J23 | T453 | Sugiyama | NSUN2 SAKI TRM4 | MPWNKRQPKLQGKSAEtREstQLsPADLTEGKPTDPSKLEs |
| Q09666 | T38 | Sugiyama | AHNAK PM227 | sGsHGLTIAQRDDGVFVQEVtQNsPAARTGVVKEGDQIVGA |
| Q12888 | S523 | Sugiyama | TP53BP1 | DLGLsLtGDsCKLMLstsEysQsPKMEsLssHRIDEDGENt |
| Q13155 | S48 | Sugiyama | AIMP2 JTV1 PRO0992 | PNVHGRSyGPAPGAGHVQEEsNLsLQALESRQDDILKRLYE |
| Q13242 | S178 | Sugiyama | SRSF9 SFRS9 SRP30C | MEYALRKLDDTKFRsHEGEtsYIRVYPERstsYGYsRsRSG |
| Q13263 | S479 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | ssAEPHVsGVKRsRsGEGEVsGLMRKVPRVsLERLDLDLtA |
| Q13283 | T241 | Sugiyama | G3BP1 G3BP | ETAPEDAQKsssPAPADIAQtVQEDLRtFsWAsVtsKNLPP |
| Q13509 | S75 | Sugiyama | TUBB3 TUBB4 | SSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIFGQS |
| Q13541 | S112 | Sugiyama | EIF4EBP1 | EAsQsHLRNsPEDKRAGGEEsQFEMDI______________ |
| Q13642 | T152 | Sugiyama | FHL1 SLIM1 | CKQVIGtGSFFPKGEDFyCVtCHETKFAKHCVKCNKAITSG |
| Q13765 | S132 | Sugiyama | NACA HSD48 | YKSPAsDtyIVFGEAKIEDLsQQAQLAAAEKFKVQGEAVsN |
| Q13885 | S75 | Sugiyama | TUBB2A TUBB2 | AGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q14151 | S207 | Sugiyama | SAFB2 KIAA0138 | FKNtLEtssLNFKVtPDIEEsLLEPENEKILDILGEtCKsE |
| Q14152 | S1256 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EDRFRRPRDEGGWRRGPAEEsssWRDssRRDDRDRDDRRRE |
| Q14152 | S1257 | Sugiyama | EIF3A EIF3S10 KIAA0139 | DRFRRPRDEGGWRRGPAEEsssWRDssRRDDRDRDDRRRER |
| Q14152 | T1378 | Sugiyama | EIF3A EIF3S10 KIAA0139 | AEKDREsLRRTKNEtDEDGWttVRR________________ |
| Q14247 | S332 | Sugiyama | CTTN EMS1 | VQKDRMDKNAstFEDVtQVssAyQKTVPVEAVtsKtsNIRA |
| Q14247 | T328 | Sugiyama | CTTN EMS1 | GKyGVQKDRMDKNAstFEDVtQVssAyQKTVPVEAVtsKts |
| Q14257 | T137 | Sugiyama | RCN2 ERC55 | VTWDEyNIQMyDRVIDFDENtALDDAEEEsFRKLHLKDKKR |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q14671 | S175 | Sugiyama | PUM1 KIAA0099 PUMH1 | TDESSKDGPKGIFLGDQWRDsAWGTsDHsVsQPIMVQRRPG |
| Q14671 | S180 | Sugiyama | PUM1 KIAA0099 PUMH1 | KDGPKGIFLGDQWRDsAWGTsDHsVsQPIMVQRRPGQsFHV |
| Q14671 | S183 | Sugiyama | PUM1 KIAA0099 PUMH1 | PKGIFLGDQWRDsAWGTsDHsVsQPIMVQRRPGQsFHVNsE |
| Q14671 | S185 | Sugiyama | PUM1 KIAA0099 PUMH1 | GIFLGDQWRDsAWGTsDHsVsQPIMVQRRPGQsFHVNsEVN |
| Q14676 | S498 | Sugiyama | MDC1 KIAA0170 NFBD1 | RALVRAHsEKDQPPFGDsDDsVEADKssPGIHLERsQAstt |
| Q14676 | S763 | Sugiyama | MDC1 KIAA0170 NFBD1 | LDEPWEVLATQPFCLREsEDsEtQPFDtHLEAyGPCLsPPR |
| Q14676 | T765 | Sugiyama | MDC1 KIAA0170 NFBD1 | EPWEVLATQPFCLREsEDsEtQPFDtHLEAyGPCLsPPRAI |
| Q14978 | S637 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | GEKRAssPFRRVREEEIEVDsRVADNsFDAKRGAAGDWGER |
| Q14978 | S643 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | sPFRRVREEEIEVDsRVADNsFDAKRGAAGDWGERANQVLK |
| Q14980 | S1181 | Sugiyama | NUMA1 NMP22 NUMA | DsALEtLQGQLEEKAQELGHsQsALAsAQRELAAFRTKVQD |
| Q15185 | S118 | Sugiyama | PTGES3 P23 TEBP | WLsVDFNNWKDWEDDsDEDMsNFDRFSEMMNNMGGDEDVDL |
| Q15185 | S72 | Sugiyama | PTGES3 P23 TEBP | EIDLFHCIDPNDsKHKRtDRsILCCLRKGEsGQsWPRLTKE |
| Q15293 | S69 | Sugiyama | RCN1 RCN | PPEDNQsFQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVD |
| Q15293 | T318 | Sugiyama | RCN1 RCN | EKLTKEEILENWNMFVGsQAtNyGEDLtKNHDEL_______ |
| Q15293 | T325 | Sugiyama | RCN1 RCN | ILENWNMFVGsQAtNyGEDLtKNHDEL______________ |
| Q15293 | T71 | Sugiyama | RCN1 RCN | EDNQsFQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVDRI |
| Q15398 | T784 | Sugiyama | DLGAP5 DLG7 KIAA0008 | LMssPEKNTAsQNsILEEGEtKIsQsELFDNKsLttECHLL |
| Q15650 | S341 | Sugiyama | TRIP4 RQT4 | RLSKKVTIDFAGRKILEEENsLAEyHSRLDETIQAIANGTL |
| Q15853 | T344 | Sugiyama | USF2 BHLHB12 | ENALLRAQLQQHNLEMVGEGtRQ__________________ |
| Q16513 | T605 | Sugiyama | PKN2 PRK2 PRKCL2 | GEIDEssELRVLDIPGQDsEtVFDIQNDRNsILPKsQsEyK |
| Q16531 | T1137 | Sugiyama | DDB1 XAP1 | GSGMKREAtADDLIKVVEELtRIH_________________ |
| Q16576 | T10 | Sugiyama | RBBP7 RBAP46 | ___________MAsKEMFEDtVEERVINEEYKIWKKNTPFL |
| Q2VIR3 | T21 | Sugiyama | EIF2S3B | MAGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAt |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q3ZCM7 | S75 | Sugiyama | TUBB8 | SGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIFGQC |
| Q5JSH3 | S71 | Sugiyama | WDR44 RPH11 | PVQELKQDVSKKIIEsIIEEsQKVLQLEDDsLDSKGKELsD |
| Q5JSH3 | S81 | Sugiyama | WDR44 RPH11 | KKIIEsIIEEsQKVLQLEDDsLDSKGKELsDQAtAsPIVAR |
| Q5QJE6 | T241 | Sugiyama | DNTTIP2 ERBP TDIF2 | IVPGNEKQIVGtPVNsEDsDtRQtsHLQARsLsEINKPNFY |
| Q5RKV6 | S14 | Sugiyama | EXOSC6 MTR3 | _______MPGDHRRIRGPEEsQPPQLyAADEEEAPGTRDPT |
| Q5T3I0 | T356 | Sugiyama | GPATCH4 GPATC4 | RKKRQQQEEEDLNLEDRGEEtVLGGGTREAESRACSDGRSR |
| Q5UIP0 | T1806 | Sugiyama | RIF1 | QFLDEHHsVNFHLGLKEDNDtINDsLIVSETKSKENTMQEs |
| Q5VTR2 | S138 | Sugiyama | RNF20 BRE1A | GDLLTERKALVVPEPEPDsDsNQERKDDRERGEGQEPAFSF |
| Q6FI81 | S307 | Sugiyama | CIAPIN1 CUA001 PRO0915 | sCPyLGMPAFKPGEKVLLsDsNLHDA_______________ |
| Q6P996 | S779 | Sugiyama | PDXDC1 KIAA0251 | QHtDQtEAFQKGVPHPEDDHsQVEGPEsLR___________ |
| Q6PEY2 | S48 | Sugiyama | TUBA3E | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q6PEY2 | T51 | Sugiyama | TUBA3E | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q6PEY2 | T73 | Sugiyama | TUBA3E | FsEtGAGKHVPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLI |
| Q6PEY2 | T80 | Sugiyama | TUBA3E | KHVPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLITGKEDAA |
| Q6PEY2 | T82 | Sugiyama | TUBA3E | VPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLITGKEDAASN |
| Q6PEY2 | Y83 | Sugiyama | TUBA3E | PRAVFVDLEPtVVDEVRtGtyRQLFHPEQLITGKEDAASNY |
| Q6UXH1 | S295 | Sugiyama | CRELD2 UNQ185/PRO211 | KECISGYAREHGQCADVDECsLAEKtCVRKNENCYNTPGSY |
| Q71U36 | S48 | Sugiyama | TUBA1A TUBA3 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q71U36 | T51 | Sugiyama | TUBA1A TUBA3 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T80 | Sugiyama | TUBA1A TUBA3 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q7KZF4 | S473 | Sugiyama | SND1 TDRD11 | ALVSKGLATVIRYRQDDDQRssHyDELLAAEARAIKNGKGL |
| Q7LBC6 | S314 | Sugiyama | KDM3B C5orf7 JHDM2B JMJD1B KIAA1082 | GCDPASKKLKGDRGEVDsNGsDGGEAsRGPWKGGNASGEPG |
| Q7LBC6 | S320 | Sugiyama | KDM3B C5orf7 JHDM2B JMJD1B KIAA1082 | KKLKGDRGEVDsNGsDGGEAsRGPWKGGNASGEPGLDQRAK |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q7Z417 | T117 | Sugiyama | NUFIP2 KIAA1321 PIG1 | LNGNAGEREISLKNLssDEAtNPIsRVLNGNQQVVDTsLKQ |
| Q7Z5K2 | T127 | Sugiyama | WAPL FOE KIAA0261 WAPAL | EEVTSVLEANSKISHVVVEDtVVsDKCFPLEDTLLGKEKST |
| Q86TU7 | S505 | Sugiyama | SETD3 C14orf154 | NREYYRQQMEEKAPLPKyEEsNLGLLEssVGDSRLPLVLRN |
| Q86UE4 | S323 | Sugiyama | MTDH AEG1 LYRIC | KWNsVsPAsAGKRKtEPSAWsQDtGDANtNGKDWGRsWsDR |
| Q86UE4 | T326 | Sugiyama | MTDH AEG1 LYRIC | sVsPAsAGKRKtEPSAWsQDtGDANtNGKDWGRsWsDRsIF |
| Q86UE4 | T331 | Sugiyama | MTDH AEG1 LYRIC | sAGKRKtEPSAWsQDtGDANtNGKDWGRsWsDRsIFsGIGs |
| Q86UE8 | S103 | Sugiyama | TLK2 | KIsDyFEFAGGsAPGtsPGRsVPPVARssPQHsLsNPLPRR |
| Q86UE8 | S111 | Sugiyama | TLK2 | AGGsAPGtsPGRsVPPVARssPQHsLsNPLPRRVEQPLYGL |
| Q86UE8 | S115 | Sugiyama | TLK2 | APGtsPGRsVPPVARssPQHsLsNPLPRRVEQPLYGLDGsA |
| Q86UE8 | S117 | Sugiyama | TLK2 | GtsPGRsVPPVARssPQHsLsNPLPRRVEQPLYGLDGsAAK |
| Q86UE8 | S134 | Sugiyama | TLK2 | HsLsNPLPRRVEQPLYGLDGsAAKEATEEQSALPTLMSVML |
| Q86UE8 | S307 | Sugiyama | TLK2 | DKSMQDRLRLGHFtTVRHGAsFtEQWtDGYAFQNLIKQQER |
| Q86UE8 | S450 | Sugiyama | TLK2 | LERVRNLHIRELKRIHNEDNsQFKDHPTLNDRYLLLHLLGR |
| Q86UE8 | S686 | Sugiyama | TLK2 | SVGVIFYQCLYGRKPFGHNQsQQDILQENtILKATEVQFPP |
| Q86UE8 | S85 | Sugiyama | TLK2 | RKAEPYETsQGKGtPRGHKIsDyFEFAGGsAPGtsPGRsVP |
| Q86UE8 | S94 | Sugiyama | TLK2 | QGKGtPRGHKIsDyFEFAGGsAPGtsPGRsVPPVARssPQH |
| Q86UE8 | S99 | Sugiyama | TLK2 | PRGHKIsDyFEFAGGsAPGtsPGRsVPPVARssPQHsLsNP |
| Q86UE8 | T161 | Sugiyama | TLK2 | EEQSALPTLMSVMLAKPRLDtEQLAQRGAGLCFTFVsAQQN |
| Q86UE8 | T300 | Sugiyama | TLK2 | QEKMACRDKSMQDRLRLGHFtTVRHGAsFtEQWtDGYAFQN |
| Q86UE8 | T309 | Sugiyama | TLK2 | SMQDRLRLGHFtTVRHGAsFtEQWtDGYAFQNLIKQQERIN |
| Q86UE8 | T313 | Sugiyama | TLK2 | RLRLGHFtTVRHGAsFtEQWtDGYAFQNLIKQQERINSQRE |
| Q86UE8 | T357 | Sugiyama | TLK2 | RQRKMLAKRKPPAMGQAPPAtNEQKQRKSKTNGAENETPSS |
| Q86UE8 | T483 | Sugiyama | TLK2 | LLLHLLGRGGFSEVYKAFDLtEQRYVAVKIHQLNKNWRDEK |
| Q86UE8 | T695 | Sugiyama | TLK2 | LYGRKPFGHNQsQQDILQENtILKATEVQFPPKPVVTPEAK |
| Q86UE8 | T98 | Sugiyama | TLK2 | tPRGHKIsDyFEFAGGsAPGtsPGRsVPPVARssPQHsLsN |
| Q86W92 | S1009 | Sugiyama | PPFIBP1 KIAA1230 | DDMFKDFAARsPsAsItDEDsNV__________________ |
| Q86W92 | T798 | Sugiyama | PPFIBP1 KIAA1230 | VLRINNFEPNCLRRRPsDENtIAPSEVQKWTNHRVMEWLRS |
| Q8N392 | S209 | Sugiyama | ARHGAP18 | TEsQSLRTNENKYQGRDDEAsNLVGEEKLIPPEETPAPETD |
| Q8N6T3 | S174 | Sugiyama | ARFGAP1 ARF1GAP | QsVtAssDKAFEDWLNDDLGsyQGAQGNRyVGFGNtPPPQK |
| Q8N6T3 | S348 | Sugiyama | ARFGAP1 ARF1GAP | FWETFGSAEPTKtRKsPssDsWtCADtstERRssDsWEVWG |
| Q8N6T3 | T350 | Sugiyama | ARFGAP1 ARF1GAP | ETFGSAEPTKtRKsPssDsWtCADtstERRssDsWEVWGSA |
| Q8N6T3 | T354 | Sugiyama | ARFGAP1 ARF1GAP | SAEPTKtRKsPssDsWtCADtstERRssDsWEVWGSASTNR |
| Q8NBK3 | S357 | Sugiyama | SUMF1 PSEC0152 UNQ3037/PRO9852 | HRSYCYRYRCAARSQNTPDSsAsNLGFRCAADRLPtMD___ |
| Q8NBK3 | S359 | Sugiyama | SUMF1 PSEC0152 UNQ3037/PRO9852 | SYCYRYRCAARSQNTPDSsAsNLGFRCAADRLPtMD_____ |
| Q8NDV7 | S883 | Sugiyama | TNRC6A CAGH26 KIAA1460 TNRC6 | NNHWGEANKKSSsGGsDSDRsVSGWNELGKTSSFTWGNNIN |
| Q8NE71 | S595 | Sugiyama | ABCF1 ABC50 | TKEALTRKQQKCRRKNQDEEsQEAPELLKRPKEYTVRFTFP |
| Q8NEF9 | S279 | Sugiyama | SRFBP1 | EYFDDstEERFYKQSsMSEDsDsGDDFFIGKVRRTRKKESS |
| Q8NEF9 | S281 | Sugiyama | SRFBP1 | FDDstEERFYKQSsMSEDsDsGDDFFIGKVRRTRKKESSCH |
| Q8TA86 | T168 | Sugiyama | RP9 | NKRHEKDVRIQQLKQLLEDstSDEDRSSSSSSEGKEKHKKK |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8WVC0 | S72 | Sugiyama | LEO1 RDL | DSGQPSNKELFGDDsEDEGAsHHsGSDNHSERSDNRsEAsE |
| Q8WWM7 | S563 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | EELRKFGAQFKLQPsssPENsLDPFPPRILKEEPKGKEKEV |
| Q92688 | T126 | Sugiyama | ANP32B APRIL PHAPI2 | LEPLKKLECLKsLDLFNCEVtNLNDyREsVFKLLPQLTYLD |
| Q92688 | Y131 | Sugiyama | ANP32B APRIL PHAPI2 | KLECLKsLDLFNCEVtNLNDyREsVFKLLPQLTYLDGyDRE |
| Q92900 | S1107 | Sugiyama | UPF1 KIAA0221 RENT1 | ELsQDSYLGDEFKsQIDVALsQDstyQGERAyQHGGVtGLs |
| Q92974 | S953 | Sugiyama | ARHGEF2 KIAA0651 LFP40 | PEERLQDssDPDtGsEEEGssRLsPPHsPRDFtRMQDIPEE |
| Q92974 | S976 | Sugiyama | ARHGEF2 KIAA0651 LFP40 | sPPHsPRDFtRMQDIPEEtEsRDGEAVASES__________ |
| Q96B36 | T233 | Sugiyama | AKT1S1 PRAS40 | PDLDRIAAsMRALVLREAEDtQVFGDLPRPRLNtsDFQKLK |
| Q96CT7 | S122 | Sugiyama | CCDC124 | DtLRRDHQLREAPDTAEKAKsHLEVPLEENVNRRVLEEGsV |
| Q96CT7 | S141 | Sugiyama | CCDC124 | KsHLEVPLEENVNRRVLEEGsVEARTIEDAIAVLsVAEEAA |
| Q96D15 | S76 | Sugiyama | RCN3 UNQ239/PRO272 | HEAFLGREVAKEFDQLtPEEsQARLGRIVDRMDRAGDGDGW |
| Q96G46 | T82 | Sugiyama | DUS3L | PAGNELAEPEAKRIRLEDGQtADGQtEEAAEPGEQLQtQKR |
| Q96HE7 | T148 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | IEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSDNFCEA |
| Q99460 | S305 | Sugiyama | PSMD1 | GTVPGsEKDsDsMEtEEKTSsAFVGKtPEAsPEPKDQTLKM |
| Q99832 | T351 | Sugiyama | CCT7 CCTH NIP7-1 | QtSVNALSADVLGRCQVFEEtQIGGERyNFFtGCPKAKTCt |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BQE3 | S48 | Sugiyama | TUBA1C TUBA6 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q9BQE3 | T51 | Sugiyama | TUBA1C TUBA6 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T80 | Sugiyama | TUBA1C TUBA6 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q9BRA2 | S8 | Sugiyama | TXNDC17 TXNL5 | _____________MARYEEVsVSGFEEFHRAVEQHNGKTIF |
| Q9BRS2 | S21 | Sugiyama | RIOK1 RIO1 | MDYRRLLMSRVVPGQFDDADssDsENRDLKTVKEKDDILFE |
| Q9BSJ8 | S1086 | Sugiyama | ESYT1 FAM62A KIAA0747 MBC2 | MsRERELLGKVQLDLAETDLsQGVARWYDLMDNKDKGss__ |
| Q9BVA1 | S75 | Sugiyama | TUBB2B | tGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q9BVS4 | S385 | Sugiyama | RIOK2 RIO2 | CYCRssGDPEQIKEDsLsEEsADARsFEMTEFNQALEEIKG |
| Q9BW91 | S343 | Sugiyama | NUDT9 NUDT10 PSEC0099 UNQ3012/PRO9771 | SHSQFIKLVAEKRDAHWSEDsEADCHAL_____________ |
| Q9BY43 | T98 | Sugiyama | CHMP4A C14orf123 SHAX2 CDA04 HSPC134 | QTDGtLStLEFQREAIENATtNAEVLRTMELAAQSMKKAYQ |
| Q9C086 | S127 | Sugiyama | INO80B HMGA1L4 PAPA1 ZNHIT4 | EEEPMEGVPLEQYRAWLDEDsNLsPsPLRDLsGGLGGQEEE |
| Q9C0C2 | S1054 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | HVPDGALGQRDQssWQNsDAsQEVGGHQERQQAGAQGPGsA |
| Q9C0C2 | S1110 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | FSLSVGPQREAAFsPGQQDWsRDFCIEASERsyQFGIIGND |
| Q9C0C2 | S1173 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | KttAGsVDWTDQLGLRNLEVssCVGsGGssEAREsAVGQMG |
| Q9C0C2 | S804 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | EGSTREWASRCGIGQEEMEAsSsQDQSKVSAPGVLTAQDRV |
| Q9H4L7 | S239 | Sugiyama | SMARCAD1 KIAA1122 | EDEFNDDQSIKKtRLDHGEEsNEsAEsSsNWEKQESIVLKL |
| Q9H4L7 | T231 | Sugiyama | SMARCAD1 KIAA1122 | ssssEPyEEDEFNDDQSIKKtRLDHGEEsNEsAEsSsNWEK |
| Q9H501 | S79 | Sugiyama | ESF1 ABTAP C20orf6 HDCMC28P | PISHSTTEDLKRFyDLsDsDsNLsGEDSKALSQKKIKKKKT |
| Q9H7L9 | T91 | Sugiyama | SUDS3 SAP45 SDS3 | QMYQDKLASLKRQLQQLQEGtLQEYQKRMKKLDQQYKERIR |
| Q9H814 | S226 | Sugiyama | PHAX RNUXA | RLGNRPEMNYKGRYEITAEDsQEKVADEISFRLQEPKKDLI |
| Q9NP61 | S374 | Sugiyama | ARFGAP3 ARFGAP1 | SSYFDEPVELRsssFssWDDssDSyWKKETSKDTETVLKTT |
| Q9NQC3 | T432 | Sugiyama | RTN4 KIAA0886 NOGO My043 SP1507 | IESNLESKVDKKCFADSLEQtNHEKDSEssNDDTsFPstPE |
| Q9NRX4 | T119 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | PAQHAISTEKIKAKyPDyEVtWANDGy______________ |
| Q9NUU7 | T73 | Sugiyama | DDX19A DDX19L | EDRAAQsLLNKLIRSNLVDNtNQVEVLQRDPNsPLysVKsF |
| Q9NVP2 | S198 | GPS6|SIGNOR|EPSD|PSP | ASF1B | CtPIKGLGLPGCIPGLLPENsMDCI________________ |
| Q9NW75 | S54 | Sugiyama | GPATCH2 GPATC2 | sALEESSEQARGGFAEtGDHsRsIsCPLKRQARKRRGRKRR |
| Q9NW75 | S56 | Sugiyama | GPATCH2 GPATC2 | LEESSEQARGGFAEtGDHsRsIsCPLKRQARKRRGRKRRSY |
| Q9NXG6 | S485 | Sugiyama | P4HTM PH4 | ARQALFQQEMARLAREGGtDsQPEWALDRAYRDARVEL___ |
| Q9P2E9 | T1120 | Sugiyama | RRBP1 KIAA1398 | PPAPAEPSSDLASKLREAEEtQstLQAECDQYRSILAETEG |
| Q9P2E9 | T1123 | Sugiyama | RRBP1 KIAA1398 | PAEPSSDLASKLREAEEtQstLQAECDQYRSILAETEGMLR |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UI30 | S125 | Sugiyama | TRMT112 AD-001 HSPC152 HSPC170 | RMFPISRGIPNMLLsEEEtEs____________________ |
| Q9UKI8 | S679 | Sugiyama | TLK1 KIAA0137 | SVGVIFFQCLYGRKPFGHNQsQQDILQENtILKATEVQFPV |
| Q9UKI8 | T304 | Sugiyama | TLK1 KIAA0137 | QEKLSSREKSMQDRLRLGHFtTVRHGASFTEQWTDGFAFQN |
| Q9UKI8 | T688 | Sugiyama | TLK1 KIAA0137 | LYGRKPFGHNQsQQDILQENtILKATEVQFPVKPVVSSEAK |
| Q9UMR2 | T74 | Sugiyama | DDX19B DBP5 DDX19 TDBP | EDRAAQsLLNKLIRSNLVDNtNQVEVLQRDPNsPLysVKsF |
| Q9UPQ0 | S201 | Sugiyama | LIMCH1 KIAA1102 | DCWDsERsDsLsPPRHGRDDsFDsLDsFGsRsRQtPsPDVV |
| Q9UPQ0 | S204 | Sugiyama | LIMCH1 KIAA1102 | DsERsDsLsPPRHGRDDsFDsLDsFGsRsRQtPsPDVVLRG |
| Q9UQ35 | S2459 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | LLPPAQDQPRsPVPsAFsDQsRCLIAQTTPVAGSQSLSSGA |
| Q9Y294 | S192 | GPS6|SIGNOR|EPSD|PSP | ASF1A CGI-98 HSPC146 | sLLstDALPsAsKGWSTSENsLNVMLESHMDCM________ |
| Q9Y2B0 | S63 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | AQVDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLE |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y450 | S67 | Sugiyama | HBS1L HBS1 KIAA1038 | KPsVEPVEEyDyEDLKEssNsVsNHQLSGFDQARLYsCLDH |
| Q9Y4L1 | S742 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | KLQDLTLRDLEKQEREKAANsLEAFIFEtQDKLyQPEyQEV |
| Q9Y4L1 | T750 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | DLEKQEREKAANsLEAFIFEtQDKLyQPEyQEVsTEEQREE |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 2.442491e-15 | 14.612 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.139089e-13 | 12.943 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.211521e-09 | 8.917 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.704030e-09 | 8.769 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.357470e-08 | 7.867 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.041006e-08 | 7.517 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 4.313457e-08 | 7.365 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.344795e-08 | 7.362 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 5.123879e-08 | 7.290 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 6.715477e-08 | 7.173 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 6.715477e-08 | 7.173 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 8.382905e-08 | 7.077 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.076823e-07 | 6.968 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.151693e-07 | 6.939 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.453804e-07 | 6.837 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.280249e-07 | 6.484 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 8.488296e-07 | 6.071 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 9.355737e-07 | 6.029 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.147422e-06 | 5.668 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.223088e-06 | 5.653 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.798427e-06 | 5.553 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.245416e-06 | 5.489 | 0 | 0 |
| Kinesins | R-HSA-983189 | 4.944757e-06 | 5.306 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.403069e-06 | 5.194 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 6.570216e-06 | 5.182 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 8.222830e-06 | 5.085 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.212093e-05 | 4.916 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.243000e-05 | 4.906 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.329024e-05 | 4.876 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.465378e-05 | 4.834 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.903484e-05 | 4.720 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.166415e-05 | 4.664 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.166415e-05 | 4.664 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.098848e-05 | 4.678 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.343419e-05 | 4.630 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.754708e-05 | 4.560 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.396014e-05 | 4.357 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 4.121117e-05 | 4.385 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.836447e-05 | 4.416 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 3.657065e-05 | 4.437 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 4.389089e-05 | 4.358 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 3.598790e-05 | 4.444 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.529032e-05 | 4.452 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.549113e-05 | 4.342 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 5.146018e-05 | 4.289 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 5.017556e-05 | 4.300 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 5.545763e-05 | 4.256 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 5.354952e-05 | 4.271 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 5.860739e-05 | 4.232 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 5.849553e-05 | 4.233 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 5.828466e-05 | 4.234 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 6.413573e-05 | 4.193 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 6.650275e-05 | 4.177 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.831431e-05 | 4.106 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 7.883854e-05 | 4.103 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 8.226923e-05 | 4.085 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 8.449836e-05 | 4.073 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 8.493626e-05 | 4.071 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 9.322573e-05 | 4.030 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.348316e-05 | 4.029 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 9.382123e-05 | 4.028 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.040998e-04 | 3.983 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.045595e-04 | 3.981 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.045595e-04 | 3.981 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.052396e-04 | 3.978 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.109270e-04 | 3.955 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.214550e-04 | 3.916 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.214550e-04 | 3.916 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.342158e-04 | 3.872 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.437819e-04 | 3.842 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.462983e-04 | 3.835 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.642152e-04 | 3.785 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.685994e-04 | 3.773 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.685994e-04 | 3.773 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.826160e-04 | 3.738 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.778541e-04 | 3.750 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.778541e-04 | 3.750 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.195499e-04 | 3.658 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.443448e-04 | 3.612 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.514644e-04 | 3.600 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.896266e-04 | 3.538 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.827702e-04 | 3.549 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.133548e-04 | 3.504 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 3.167318e-04 | 3.499 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.391790e-04 | 3.470 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.444214e-04 | 3.463 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.566656e-04 | 3.448 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 3.718054e-04 | 3.430 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.751774e-04 | 3.426 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 3.768256e-04 | 3.424 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.933223e-04 | 3.405 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.996627e-04 | 3.398 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 4.030971e-04 | 3.395 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.036280e-04 | 3.394 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 4.817968e-04 | 3.317 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.871367e-04 | 3.312 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 5.012406e-04 | 3.300 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 5.141511e-04 | 3.289 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.356077e-04 | 3.271 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 5.194886e-04 | 3.284 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 5.116311e-04 | 3.291 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 5.434335e-04 | 3.265 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.770138e-04 | 3.239 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 5.800250e-04 | 3.237 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 6.084452e-04 | 3.216 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 6.263140e-04 | 3.203 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 6.303840e-04 | 3.200 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.422966e-04 | 3.192 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 7.148753e-04 | 3.146 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 7.247789e-04 | 3.140 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 7.305759e-04 | 3.136 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 7.635113e-04 | 3.117 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 7.635113e-04 | 3.117 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 8.069177e-04 | 3.093 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 8.345320e-04 | 3.079 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.486865e-04 | 3.071 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 8.405403e-04 | 3.075 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 8.758343e-04 | 3.058 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 8.758343e-04 | 3.058 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 8.712549e-04 | 3.060 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 8.970621e-04 | 3.047 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 9.070742e-04 | 3.042 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.392762e-04 | 3.027 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 9.571183e-04 | 3.019 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 9.627348e-04 | 3.016 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 9.627348e-04 | 3.016 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 9.714489e-04 | 3.013 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.044918e-03 | 2.981 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.098606e-03 | 2.959 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.207759e-03 | 2.918 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.212821e-03 | 2.916 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.213485e-03 | 2.916 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.249949e-03 | 2.903 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.264583e-03 | 2.898 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.365323e-03 | 2.865 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.400006e-03 | 2.854 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.400006e-03 | 2.854 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.400006e-03 | 2.854 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.296602e-03 | 2.887 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.391889e-03 | 2.856 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.463981e-03 | 2.834 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 1.484978e-03 | 2.828 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 1.484978e-03 | 2.828 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.492932e-03 | 2.826 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.519606e-03 | 2.818 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.548158e-03 | 2.810 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.582185e-03 | 2.801 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.582802e-03 | 2.801 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.593928e-03 | 2.798 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.629248e-03 | 2.788 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.629248e-03 | 2.788 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.704663e-03 | 2.768 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.026200e-03 | 2.693 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.854418e-03 | 2.732 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.967772e-03 | 2.706 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.130042e-03 | 2.672 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.279128e-03 | 2.642 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.367693e-03 | 2.626 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.367963e-03 | 2.626 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.292370e-03 | 2.640 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.412334e-03 | 2.618 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.346069e-03 | 2.630 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.298989e-03 | 2.638 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.292370e-03 | 2.640 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.186232e-03 | 2.660 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.346069e-03 | 2.630 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.434432e-03 | 2.614 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 2.484445e-03 | 2.605 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.494853e-03 | 2.603 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.531688e-03 | 2.597 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.620310e-03 | 2.582 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.646491e-03 | 2.577 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.691698e-03 | 2.570 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.911931e-03 | 2.536 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.951212e-03 | 2.530 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.974962e-03 | 2.527 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.086405e-03 | 2.511 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 3.241884e-03 | 2.489 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.246058e-03 | 2.489 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 3.246058e-03 | 2.489 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.471927e-03 | 2.459 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 3.291059e-03 | 2.483 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.661585e-03 | 2.436 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 3.353501e-03 | 2.475 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.432872e-03 | 2.464 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.555096e-03 | 2.449 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 3.675886e-03 | 2.435 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 3.702881e-03 | 2.431 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 3.702881e-03 | 2.431 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.702881e-03 | 2.431 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 3.703255e-03 | 2.431 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 3.852255e-03 | 2.414 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.466180e-03 | 2.350 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.466180e-03 | 2.350 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.466180e-03 | 2.350 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.466180e-03 | 2.350 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.466180e-03 | 2.350 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.466180e-03 | 2.350 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.466180e-03 | 2.350 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.466180e-03 | 2.350 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.466180e-03 | 2.350 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.466180e-03 | 2.350 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.466180e-03 | 2.350 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 3.979911e-03 | 2.400 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 4.323607e-03 | 2.364 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 3.976233e-03 | 2.401 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 4.574189e-03 | 2.340 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 4.585228e-03 | 2.339 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 4.585228e-03 | 2.339 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 4.589461e-03 | 2.338 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 4.590292e-03 | 2.338 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.631310e-03 | 2.334 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 4.648629e-03 | 2.333 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.861935e-03 | 2.313 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 5.211195e-03 | 2.283 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.223414e-03 | 2.282 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.240688e-03 | 2.281 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.273162e-03 | 2.278 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.358059e-03 | 2.271 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 6.262649e-03 | 2.203 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 6.262649e-03 | 2.203 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.262649e-03 | 2.203 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 6.074575e-03 | 2.216 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 6.074575e-03 | 2.216 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 5.596267e-03 | 2.252 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 5.931258e-03 | 2.227 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 5.585494e-03 | 2.253 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 6.105108e-03 | 2.214 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 5.780144e-03 | 2.238 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 6.074575e-03 | 2.216 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 5.931258e-03 | 2.227 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 5.780144e-03 | 2.238 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 5.596267e-03 | 2.252 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.839217e-03 | 2.234 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 5.812502e-03 | 2.236 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 6.270351e-03 | 2.203 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 6.301991e-03 | 2.201 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 6.522958e-03 | 2.186 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.745112e-03 | 2.171 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 6.882792e-03 | 2.162 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 6.919381e-03 | 2.160 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 6.919381e-03 | 2.160 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.919381e-03 | 2.160 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 6.985827e-03 | 2.156 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 7.036034e-03 | 2.153 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 7.036034e-03 | 2.153 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.203853e-03 | 2.142 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.235659e-03 | 2.141 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.235659e-03 | 2.141 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 7.235659e-03 | 2.141 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 7.285988e-03 | 2.138 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.481144e-03 | 2.126 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.191814e-03 | 2.087 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.191814e-03 | 2.087 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.331436e-03 | 2.079 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 8.368327e-03 | 2.077 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 8.389157e-03 | 2.076 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 8.517734e-03 | 2.070 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 8.517734e-03 | 2.070 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 8.517734e-03 | 2.070 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.715534e-03 | 2.060 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 8.751397e-03 | 2.058 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 8.898251e-03 | 2.051 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.071004e-02 | 1.970 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 1.071004e-02 | 1.970 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.071004e-02 | 1.970 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 9.031893e-03 | 2.044 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 9.031893e-03 | 2.044 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 9.031893e-03 | 2.044 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 9.031893e-03 | 2.044 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 9.031893e-03 | 2.044 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 9.031893e-03 | 2.044 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 9.194559e-03 | 2.036 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 9.194559e-03 | 2.036 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.134407e-03 | 2.039 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.010371e-02 | 1.996 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 9.097472e-03 | 2.041 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.052994e-02 | 1.978 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 9.002439e-03 | 2.046 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 9.416462e-03 | 2.026 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.010255e-02 | 1.996 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 9.448223e-03 | 2.025 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.102057e-02 | 1.958 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.107679e-02 | 1.956 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.109722e-02 | 1.955 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.109722e-02 | 1.955 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.123199e-02 | 1.950 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.160558e-02 | 1.935 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.160558e-02 | 1.935 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 1.160558e-02 | 1.935 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.202860e-02 | 1.920 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.227540e-02 | 1.911 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.258161e-02 | 1.900 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.258161e-02 | 1.900 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.298225e-02 | 1.887 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.320837e-02 | 1.879 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.320837e-02 | 1.879 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.337325e-02 | 1.874 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.397352e-02 | 1.855 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.397352e-02 | 1.855 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.397352e-02 | 1.855 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 1.397352e-02 | 1.855 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.398295e-02 | 1.854 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 1.398295e-02 | 1.854 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.409529e-02 | 1.851 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.459681e-02 | 1.836 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.459681e-02 | 1.836 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.480016e-02 | 1.830 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.489436e-02 | 1.827 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.489436e-02 | 1.827 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.530061e-02 | 1.815 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.756414e-02 | 1.755 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.693968e-02 | 1.771 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.693968e-02 | 1.771 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 1.693968e-02 | 1.771 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 1.693968e-02 | 1.771 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.725138e-02 | 1.763 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.725138e-02 | 1.763 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.725138e-02 | 1.763 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.725138e-02 | 1.763 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.725138e-02 | 1.763 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.725138e-02 | 1.763 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.725138e-02 | 1.763 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 1.834851e-02 | 1.736 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.919505e-02 | 1.717 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.617444e-02 | 1.791 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.699372e-02 | 1.770 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.771326e-02 | 1.752 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 1.778039e-02 | 1.750 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.588819e-02 | 1.799 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.596888e-02 | 1.797 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.921561e-02 | 1.716 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.713749e-02 | 1.766 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.834851e-02 | 1.736 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 1.804621e-02 | 1.744 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.921561e-02 | 1.716 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.070731e-02 | 1.684 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.092470e-02 | 1.679 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.107120e-02 | 1.676 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 2.107120e-02 | 1.676 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 2.107120e-02 | 1.676 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.113080e-02 | 1.675 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.121320e-02 | 1.673 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 2.209106e-02 | 1.656 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.277177e-02 | 1.643 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.307016e-02 | 1.637 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.330370e-02 | 1.633 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.339578e-02 | 1.631 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.339578e-02 | 1.631 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 2.362524e-02 | 1.627 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.397214e-02 | 1.620 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.454598e-02 | 1.610 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.472276e-02 | 1.607 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.472276e-02 | 1.607 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.507842e-02 | 1.601 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.519592e-02 | 1.599 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 2.519592e-02 | 1.599 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.519592e-02 | 1.599 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.519592e-02 | 1.599 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 2.519592e-02 | 1.599 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.574911e-02 | 1.589 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.574911e-02 | 1.589 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.635699e-02 | 1.579 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.635699e-02 | 1.579 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 2.679454e-02 | 1.572 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.679454e-02 | 1.572 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.700234e-02 | 1.569 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.761475e-02 | 1.559 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.765251e-02 | 1.558 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 2.844067e-02 | 1.546 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.871492e-02 | 1.542 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 2.871492e-02 | 1.542 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.871492e-02 | 1.542 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 2.874922e-02 | 1.541 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.874922e-02 | 1.541 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 2.878283e-02 | 1.541 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.893150e-02 | 1.539 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 2.895720e-02 | 1.538 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.895720e-02 | 1.538 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 2.898420e-02 | 1.538 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.898420e-02 | 1.538 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 2.898420e-02 | 1.538 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.971341e-02 | 1.527 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.971341e-02 | 1.527 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 3.001084e-02 | 1.523 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 3.001084e-02 | 1.523 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 3.001084e-02 | 1.523 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 3.038723e-02 | 1.517 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.117226e-02 | 1.506 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.136783e-02 | 1.504 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.136783e-02 | 1.504 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 3.566353e-02 | 1.448 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 3.829620e-02 | 1.417 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 3.829620e-02 | 1.417 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.719763e-02 | 1.429 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 3.337291e-02 | 1.477 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.691378e-02 | 1.433 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.691378e-02 | 1.433 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.404465e-02 | 1.468 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 3.973810e-02 | 1.401 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.196458e-02 | 1.377 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.212353e-02 | 1.493 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.519671e-02 | 1.453 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.987326e-02 | 1.399 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.821066e-02 | 1.418 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 3.337291e-02 | 1.477 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.920448e-02 | 1.407 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 4.140674e-02 | 1.383 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.352609e-02 | 1.475 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.352609e-02 | 1.475 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.352609e-02 | 1.475 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.352609e-02 | 1.475 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.078025e-02 | 1.390 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 4.042084e-02 | 1.393 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.196458e-02 | 1.377 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.544565e-02 | 1.450 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 3.829620e-02 | 1.417 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.352609e-02 | 1.475 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.719763e-02 | 1.429 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.544565e-02 | 1.450 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 3.856380e-02 | 1.414 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 3.566353e-02 | 1.448 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 4.228285e-02 | 1.374 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 4.276579e-02 | 1.369 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 4.276579e-02 | 1.369 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 4.276579e-02 | 1.369 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 4.276579e-02 | 1.369 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 4.276579e-02 | 1.369 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 4.276579e-02 | 1.369 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 4.276579e-02 | 1.369 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 4.276579e-02 | 1.369 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 4.276579e-02 | 1.369 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 4.283187e-02 | 1.368 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 4.326485e-02 | 1.364 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 4.326485e-02 | 1.364 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 4.326485e-02 | 1.364 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 4.326485e-02 | 1.364 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.335693e-02 | 1.363 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 4.335693e-02 | 1.363 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 4.335693e-02 | 1.363 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 4.369433e-02 | 1.360 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 4.460106e-02 | 1.351 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.496869e-02 | 1.347 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 4.562479e-02 | 1.341 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 4.580226e-02 | 1.339 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 4.600801e-02 | 1.337 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 4.719316e-02 | 1.326 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 4.795328e-02 | 1.319 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.814602e-02 | 1.317 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 4.814602e-02 | 1.317 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 4.846171e-02 | 1.315 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 4.846171e-02 | 1.315 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 4.846171e-02 | 1.315 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 4.926131e-02 | 1.307 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.926131e-02 | 1.307 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 4.940373e-02 | 1.306 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 4.940373e-02 | 1.306 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.940373e-02 | 1.306 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.964388e-02 | 1.304 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 5.064402e-02 | 1.295 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 5.085003e-02 | 1.294 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 5.118635e-02 | 1.291 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.240223e-02 | 1.281 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.289800e-02 | 1.277 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 5.305780e-02 | 1.275 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 5.305780e-02 | 1.275 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 5.492900e-02 | 1.260 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.492900e-02 | 1.260 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 5.521335e-02 | 1.258 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.536598e-02 | 1.257 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 5.627460e-02 | 1.250 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 5.715341e-02 | 1.243 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.771214e-02 | 1.239 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 5.779867e-02 | 1.238 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 5.846980e-02 | 1.233 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 5.846980e-02 | 1.233 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 5.846980e-02 | 1.233 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 5.846980e-02 | 1.233 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 5.903295e-02 | 1.229 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 6.039609e-02 | 1.219 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 6.073241e-02 | 1.217 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.126053e-02 | 1.213 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 6.126053e-02 | 1.213 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 6.216939e-02 | 1.206 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 6.216939e-02 | 1.206 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 6.233251e-02 | 1.205 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.233251e-02 | 1.205 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 6.233251e-02 | 1.205 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 6.233251e-02 | 1.205 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.233251e-02 | 1.205 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.233251e-02 | 1.205 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 6.233251e-02 | 1.205 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 6.338742e-02 | 1.198 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 6.340694e-02 | 1.198 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 6.364278e-02 | 1.196 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 6.364278e-02 | 1.196 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 6.364278e-02 | 1.196 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 6.388966e-02 | 1.195 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 6.424587e-02 | 1.192 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 6.437827e-02 | 1.191 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 6.437827e-02 | 1.191 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 6.441815e-02 | 1.191 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 6.442255e-02 | 1.191 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 6.718770e-02 | 1.173 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 6.718770e-02 | 1.173 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.764994e-02 | 1.170 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 6.910894e-02 | 1.160 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 7.018142e-02 | 1.154 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 7.092727e-02 | 1.149 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 7.092727e-02 | 1.149 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 7.112009e-02 | 1.148 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 7.146131e-02 | 1.146 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 7.156454e-02 | 1.145 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 7.601159e-02 | 1.119 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 7.601159e-02 | 1.119 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 7.601159e-02 | 1.119 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 7.601159e-02 | 1.119 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 1.075956e-01 | 0.968 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.075956e-01 | 0.968 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 8.260974e-02 | 1.083 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.071068e-01 | 0.970 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 8.119487e-02 | 1.090 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 8.119487e-02 | 1.090 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 7.689204e-02 | 1.114 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.689204e-02 | 1.114 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 9.341227e-02 | 1.030 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 9.341227e-02 | 1.030 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 8.555545e-02 | 1.068 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 8.555545e-02 | 1.068 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 7.799422e-02 | 1.108 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.009915e-01 | 0.996 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 9.120972e-02 | 1.040 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 9.120972e-02 | 1.040 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.235201e-02 | 1.084 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 8.235201e-02 | 1.084 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.436869e-02 | 1.129 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 9.482089e-02 | 1.023 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.801692e-02 | 1.055 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.801692e-02 | 1.055 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.905983e-02 | 1.102 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 7.940479e-02 | 1.100 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.840773e-02 | 1.007 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.840773e-02 | 1.007 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.840773e-02 | 1.007 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.098316e-01 | 0.959 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.098316e-01 | 0.959 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.090721e-01 | 0.962 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.090721e-01 | 0.962 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.090721e-01 | 0.962 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.090721e-01 | 0.962 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 9.582188e-02 | 1.019 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 7.358927e-02 | 1.133 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 1.010473e-01 | 0.995 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.056328e-01 | 0.976 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.946971e-02 | 1.002 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 9.700191e-02 | 1.013 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 9.852292e-02 | 1.006 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.010473e-01 | 0.995 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.096831e-01 | 0.960 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.172211e-02 | 1.038 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.043811e-01 | 0.981 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 9.482089e-02 | 1.023 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 7.601159e-02 | 1.119 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.008230e-01 | 0.996 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 9.622196e-02 | 1.017 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 8.119487e-02 | 1.090 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 8.609661e-02 | 1.065 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.702458e-02 | 1.060 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 7.942482e-02 | 1.100 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.395548e-02 | 1.027 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 9.815676e-02 | 1.008 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 7.720928e-02 | 1.112 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.305756e-02 | 1.081 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 8.702458e-02 | 1.060 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 9.815676e-02 | 1.008 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 7.852294e-02 | 1.105 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 7.905983e-02 | 1.102 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 8.235201e-02 | 1.084 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.071068e-01 | 0.970 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.840773e-02 | 1.007 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 1.071068e-01 | 0.970 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 8.801692e-02 | 1.055 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.071068e-01 | 0.970 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 7.820087e-02 | 1.107 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 7.670273e-02 | 1.115 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 7.777537e-02 | 1.109 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.750355e-02 | 1.011 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 8.225058e-02 | 1.085 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.107294e-01 | 0.956 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.116805e-01 | 0.952 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.116805e-01 | 0.952 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 1.116805e-01 | 0.952 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.116805e-01 | 0.952 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.152943e-01 | 0.938 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.165948e-01 | 0.933 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.178377e-01 | 0.929 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.178377e-01 | 0.929 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.203046e-01 | 0.920 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.203926e-01 | 0.919 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.218229e-01 | 0.914 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 1.220995e-01 | 0.913 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.228512e-01 | 0.911 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.230778e-01 | 0.910 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.232596e-01 | 0.909 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.247960e-01 | 0.904 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.258577e-01 | 0.900 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.269188e-01 | 0.896 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.312450e-01 | 0.882 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.316122e-01 | 0.881 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 1.316176e-01 | 0.881 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.316176e-01 | 0.881 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.316176e-01 | 0.881 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.316176e-01 | 0.881 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.344591e-01 | 0.871 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.344591e-01 | 0.871 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.344591e-01 | 0.871 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.344591e-01 | 0.871 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 1.345234e-01 | 0.871 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.354018e-01 | 0.868 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 1.363564e-01 | 0.865 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 1.375910e-01 | 0.861 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 1.377109e-01 | 0.861 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 1.377109e-01 | 0.861 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.379885e-01 | 0.860 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.383669e-01 | 0.859 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 1.383669e-01 | 0.859 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.388318e-01 | 0.858 | 0 | 0 |
| Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization | R-HSA-180897 | 1.389691e-01 | 0.857 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.428739e-01 | 0.845 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.428739e-01 | 0.845 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.433355e-01 | 0.844 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.433355e-01 | 0.844 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 1.433355e-01 | 0.844 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 1.433355e-01 | 0.844 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.433355e-01 | 0.844 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.433355e-01 | 0.844 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.471212e-01 | 0.832 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.471212e-01 | 0.832 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.471212e-01 | 0.832 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.471212e-01 | 0.832 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.471212e-01 | 0.832 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.471212e-01 | 0.832 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.479077e-01 | 0.830 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 1.502132e-01 | 0.823 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 1.502132e-01 | 0.823 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 1.502132e-01 | 0.823 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.502132e-01 | 0.823 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 1.502132e-01 | 0.823 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 1.502132e-01 | 0.823 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 1.502132e-01 | 0.823 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 1.502132e-01 | 0.823 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 1.502132e-01 | 0.823 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 1.502132e-01 | 0.823 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.531185e-01 | 0.815 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.531185e-01 | 0.815 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 1.531185e-01 | 0.815 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.539589e-01 | 0.813 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 1.548363e-01 | 0.810 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.548363e-01 | 0.810 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 1.555267e-01 | 0.808 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.555267e-01 | 0.808 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.558318e-01 | 0.807 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.558318e-01 | 0.807 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.581894e-01 | 0.801 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 1.643125e-01 | 0.784 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.643125e-01 | 0.784 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.643125e-01 | 0.784 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.643125e-01 | 0.784 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.643125e-01 | 0.784 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.647142e-01 | 0.783 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.656596e-01 | 0.781 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.656596e-01 | 0.781 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.673734e-01 | 0.776 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.673734e-01 | 0.776 | 0 | 0 |
| MGMT-mediated DNA damage reversal | R-HSA-5657655 | 2.778697e-01 | 0.556 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.778697e-01 | 0.556 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.778697e-01 | 0.556 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.778697e-01 | 0.556 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.778697e-01 | 0.556 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 2.778697e-01 | 0.556 | 0 | 0 |
| Signaling by FGFR1 amplification mutants | R-HSA-1839120 | 1.961748e-01 | 0.707 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 1.961748e-01 | 0.707 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 1.961748e-01 | 0.707 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 1.823538e-01 | 0.739 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 1.823538e-01 | 0.739 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 1.823538e-01 | 0.739 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 2.556276e-01 | 0.592 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.556276e-01 | 0.592 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.556276e-01 | 0.592 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.556276e-01 | 0.592 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 2.556276e-01 | 0.592 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 2.237802e-01 | 0.650 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 2.237802e-01 | 0.650 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 2.237802e-01 | 0.650 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 2.237802e-01 | 0.650 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 2.237802e-01 | 0.650 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.237802e-01 | 0.650 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.962745e-01 | 0.707 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 1.962745e-01 | 0.707 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 3.153624e-01 | 0.501 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 3.153624e-01 | 0.501 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 3.153624e-01 | 0.501 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 3.153624e-01 | 0.501 | 0 | 0 |
| IRS activation | R-HSA-74713 | 3.153624e-01 | 0.501 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 3.153624e-01 | 0.501 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 3.153624e-01 | 0.501 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 3.153624e-01 | 0.501 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 3.153624e-01 | 0.501 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 2.667935e-01 | 0.574 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.667935e-01 | 0.574 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 2.667935e-01 | 0.574 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.667935e-01 | 0.574 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 2.667935e-01 | 0.574 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 2.299338e-01 | 0.638 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 2.299338e-01 | 0.638 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.299338e-01 | 0.638 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.299338e-01 | 0.638 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 2.004242e-01 | 0.698 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.004242e-01 | 0.698 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.648773e-01 | 0.577 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.648773e-01 | 0.577 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 2.648773e-01 | 0.577 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.648773e-01 | 0.577 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.648773e-01 | 0.577 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.648773e-01 | 0.577 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.648773e-01 | 0.577 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.106474e-01 | 0.508 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.106474e-01 | 0.508 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 3.106474e-01 | 0.508 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.106474e-01 | 0.508 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.106474e-01 | 0.508 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 1.979919e-01 | 0.703 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 2.591086e-01 | 0.587 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.591086e-01 | 0.587 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 2.591086e-01 | 0.587 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 3.007024e-01 | 0.522 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 3.007024e-01 | 0.522 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.207594e-01 | 0.656 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.691193e-01 | 0.772 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 1.691193e-01 | 0.772 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 2.152477e-01 | 0.667 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 2.152477e-01 | 0.667 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 1.860002e-01 | 0.730 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.898438e-01 | 0.538 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.766972e-01 | 0.753 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 3.370280e-01 | 0.472 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 3.370280e-01 | 0.472 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 3.370280e-01 | 0.472 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.211746e-01 | 0.493 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 3.211746e-01 | 0.493 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 2.589397e-01 | 0.587 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 2.496125e-01 | 0.603 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 2.013618e-01 | 0.696 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.937618e-01 | 0.532 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.937618e-01 | 0.532 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.937618e-01 | 0.532 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.192363e-01 | 0.496 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.192363e-01 | 0.496 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.801435e-01 | 0.553 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 2.491910e-01 | 0.603 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.491910e-01 | 0.603 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.378317e-01 | 0.624 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.766765e-01 | 0.558 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.832044e-01 | 0.548 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.832044e-01 | 0.548 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.949082e-01 | 0.530 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 2.949082e-01 | 0.530 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.949082e-01 | 0.530 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.134653e-01 | 0.504 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 3.322988e-01 | 0.478 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 2.856605e-01 | 0.544 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.246602e-01 | 0.648 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 1.691193e-01 | 0.772 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 2.036044e-01 | 0.691 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 2.801487e-01 | 0.553 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.079449e-01 | 0.682 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 2.036044e-01 | 0.691 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.207594e-01 | 0.656 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.207594e-01 | 0.656 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 2.001440e-01 | 0.699 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.207594e-01 | 0.656 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 2.036044e-01 | 0.691 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.519775e-01 | 0.599 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 2.407687e-01 | 0.618 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 3.007024e-01 | 0.522 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 2.161933e-01 | 0.665 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.519775e-01 | 0.599 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.860002e-01 | 0.730 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 2.505017e-01 | 0.601 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.292178e-01 | 0.640 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.106474e-01 | 0.508 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.937618e-01 | 0.532 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.938832e-01 | 0.532 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 2.002854e-01 | 0.698 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.263237e-01 | 0.486 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 1.762107e-01 | 0.754 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.722132e-01 | 0.764 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 2.898438e-01 | 0.538 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 2.496125e-01 | 0.603 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.096511e-01 | 0.679 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 2.881305e-01 | 0.540 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.697902e-01 | 0.569 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.434242e-01 | 0.614 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.057336e-01 | 0.687 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 1.823538e-01 | 0.739 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.556276e-01 | 0.592 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 3.153624e-01 | 0.501 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 3.106474e-01 | 0.508 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 3.211746e-01 | 0.493 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 3.211746e-01 | 0.493 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.766765e-01 | 0.558 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.623980e-01 | 0.581 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 3.057864e-01 | 0.515 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.488379e-01 | 0.604 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.715818e-01 | 0.766 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.292178e-01 | 0.640 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.361718e-01 | 0.473 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.097690e-01 | 0.678 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 2.027705e-01 | 0.693 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.302650e-01 | 0.481 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.236606e-01 | 0.650 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.211746e-01 | 0.493 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.164622e-01 | 0.665 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 2.327850e-01 | 0.633 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.898799e-01 | 0.722 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 2.161933e-01 | 0.665 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.556276e-01 | 0.592 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 3.153624e-01 | 0.501 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.004242e-01 | 0.698 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.860002e-01 | 0.730 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 3.370280e-01 | 0.472 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.977713e-01 | 0.704 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 2.407687e-01 | 0.618 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.766972e-01 | 0.753 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.966382e-01 | 0.706 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.147851e-01 | 0.668 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.034421e-01 | 0.518 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.491910e-01 | 0.603 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 2.011960e-01 | 0.696 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.259544e-01 | 0.487 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.722660e-01 | 0.565 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.237802e-01 | 0.650 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.729782e-01 | 0.762 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.519775e-01 | 0.599 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.322988e-01 | 0.478 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.982850e-01 | 0.703 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 3.366158e-01 | 0.473 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 3.153624e-01 | 0.501 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.589397e-01 | 0.587 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 3.192363e-01 | 0.496 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.401439e-01 | 0.620 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 2.560325e-01 | 0.592 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.443941e-01 | 0.612 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.367461e-01 | 0.626 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 1.838697e-01 | 0.735 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.778697e-01 | 0.556 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.778697e-01 | 0.556 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.961748e-01 | 0.707 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 3.153624e-01 | 0.501 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 3.153624e-01 | 0.501 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.667935e-01 | 0.574 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 2.667935e-01 | 0.574 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.299338e-01 | 0.638 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.760560e-01 | 0.754 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.002854e-01 | 0.698 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.106474e-01 | 0.508 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 3.007024e-01 | 0.522 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 2.898438e-01 | 0.538 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 2.443941e-01 | 0.612 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 3.211746e-01 | 0.493 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.505017e-01 | 0.601 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.401439e-01 | 0.620 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.674525e-01 | 0.573 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.350270e-01 | 0.475 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.747058e-01 | 0.758 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.949082e-01 | 0.530 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.645358e-01 | 0.578 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.560325e-01 | 0.592 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 2.237802e-01 | 0.650 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 3.106474e-01 | 0.508 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.766972e-01 | 0.753 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.519775e-01 | 0.599 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 1.798511e-01 | 0.745 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 2.937618e-01 | 0.532 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.691038e-01 | 0.570 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 2.648773e-01 | 0.577 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 2.648773e-01 | 0.577 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.106474e-01 | 0.508 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 3.068408e-01 | 0.513 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 3.068408e-01 | 0.513 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.691193e-01 | 0.772 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.760560e-01 | 0.754 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 2.556276e-01 | 0.592 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 2.648773e-01 | 0.577 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 2.790999e-01 | 0.554 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 3.038187e-01 | 0.517 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.057864e-01 | 0.515 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 3.139496e-01 | 0.503 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.350270e-01 | 0.475 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 3.393126e-01 | 0.469 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 3.393126e-01 | 0.469 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 3.393126e-01 | 0.469 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.403319e-01 | 0.468 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 3.420956e-01 | 0.466 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 3.421834e-01 | 0.466 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 3.421834e-01 | 0.466 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 3.421834e-01 | 0.466 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 3.422130e-01 | 0.466 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.435579e-01 | 0.464 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.435579e-01 | 0.464 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 3.526795e-01 | 0.453 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 3.526795e-01 | 0.453 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 3.526795e-01 | 0.453 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.526795e-01 | 0.453 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.528606e-01 | 0.452 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.528606e-01 | 0.452 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.528606e-01 | 0.452 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 3.546839e-01 | 0.450 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.546839e-01 | 0.450 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 3.548867e-01 | 0.450 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 3.627631e-01 | 0.440 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.634896e-01 | 0.440 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 3.673483e-01 | 0.435 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.679349e-01 | 0.434 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 3.711216e-01 | 0.430 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.711216e-01 | 0.430 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 3.735010e-01 | 0.428 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 3.735010e-01 | 0.428 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 3.735010e-01 | 0.428 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 3.735010e-01 | 0.428 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 3.735010e-01 | 0.428 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.739535e-01 | 0.427 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 3.739535e-01 | 0.427 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 3.739535e-01 | 0.427 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 3.739535e-01 | 0.427 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 3.739535e-01 | 0.427 | 0 | 0 |
| Proton/oligopeptide cotransporters | R-HSA-427975 | 3.739535e-01 | 0.427 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 3.739535e-01 | 0.427 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 3.768511e-01 | 0.424 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.840152e-01 | 0.416 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 3.846741e-01 | 0.415 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 3.846741e-01 | 0.415 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 3.846741e-01 | 0.415 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 3.848064e-01 | 0.415 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.861599e-01 | 0.413 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 3.863556e-01 | 0.413 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 3.863556e-01 | 0.413 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.863556e-01 | 0.413 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 3.863556e-01 | 0.413 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 3.863556e-01 | 0.413 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.863556e-01 | 0.413 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 3.863556e-01 | 0.413 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 3.863556e-01 | 0.413 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.863556e-01 | 0.413 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 3.863556e-01 | 0.413 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 3.863556e-01 | 0.413 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 3.863556e-01 | 0.413 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 3.863556e-01 | 0.413 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.863556e-01 | 0.413 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.863556e-01 | 0.413 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.863556e-01 | 0.413 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.863556e-01 | 0.413 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.863556e-01 | 0.413 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.863556e-01 | 0.413 | 0 | 0 |
| Inhibition of membrane repair | R-HSA-9635644 | 3.863556e-01 | 0.413 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.863556e-01 | 0.413 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 3.876421e-01 | 0.412 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 3.889540e-01 | 0.410 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.889936e-01 | 0.410 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 3.899579e-01 | 0.409 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 3.920663e-01 | 0.407 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.920663e-01 | 0.407 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 3.983388e-01 | 0.400 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 3.983388e-01 | 0.400 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 3.983388e-01 | 0.400 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 3.983388e-01 | 0.400 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.995434e-01 | 0.398 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 4.011193e-01 | 0.397 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 4.040234e-01 | 0.394 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.062645e-01 | 0.391 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.080169e-01 | 0.389 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 4.093982e-01 | 0.388 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 4.098017e-01 | 0.387 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 4.098017e-01 | 0.387 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 4.098017e-01 | 0.387 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 4.098017e-01 | 0.387 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 4.098017e-01 | 0.387 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 4.113547e-01 | 0.386 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 4.113547e-01 | 0.386 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 4.113547e-01 | 0.386 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.113547e-01 | 0.386 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.164030e-01 | 0.380 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 4.164030e-01 | 0.380 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 4.206035e-01 | 0.376 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 4.206035e-01 | 0.376 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 4.232184e-01 | 0.373 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 4.253900e-01 | 0.371 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 4.259133e-01 | 0.371 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 4.292754e-01 | 0.367 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 4.303969e-01 | 0.366 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 4.303969e-01 | 0.366 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 4.303969e-01 | 0.366 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 4.303969e-01 | 0.366 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 4.303969e-01 | 0.366 | 0 | 0 |
| Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells | R-HSA-210746 | 4.303969e-01 | 0.366 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 4.399991e-01 | 0.357 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.411411e-01 | 0.355 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 4.411411e-01 | 0.355 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.411411e-01 | 0.355 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 4.411411e-01 | 0.355 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 4.411411e-01 | 0.355 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 4.456461e-01 | 0.351 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 4.456461e-01 | 0.351 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.489575e-01 | 0.348 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.489575e-01 | 0.348 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.491787e-01 | 0.348 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.491787e-01 | 0.348 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 4.494508e-01 | 0.347 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 4.494508e-01 | 0.347 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 4.494508e-01 | 0.347 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 4.494567e-01 | 0.347 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 4.638802e-01 | 0.334 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 4.677055e-01 | 0.330 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.703412e-01 | 0.328 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 4.710011e-01 | 0.327 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.720104e-01 | 0.326 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.720104e-01 | 0.326 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.735843e-01 | 0.325 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.752430e-01 | 0.323 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 4.752430e-01 | 0.323 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 4.752430e-01 | 0.323 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 4.752430e-01 | 0.323 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 4.760802e-01 | 0.322 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 4.769961e-01 | 0.321 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 4.769961e-01 | 0.321 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.769961e-01 | 0.321 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 4.785489e-01 | 0.320 | 0 | 0 |
| Defective ALG9 causes CDG-1l | R-HSA-4720454 | 4.785489e-01 | 0.320 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.785489e-01 | 0.320 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 4.785489e-01 | 0.320 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 4.785489e-01 | 0.320 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 4.785489e-01 | 0.320 | 0 | 0 |
| Defective SLC12A1 causes Bartter syndrome 1 (BS1) | R-HSA-5619104 | 4.785489e-01 | 0.320 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 4.785489e-01 | 0.320 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 4.785489e-01 | 0.320 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 4.785489e-01 | 0.320 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 4.785489e-01 | 0.320 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 4.785489e-01 | 0.320 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 4.785489e-01 | 0.320 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.785489e-01 | 0.320 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 4.785489e-01 | 0.320 | 0 | 0 |
| Influenza Virus Induced Apoptosis | R-HSA-168277 | 4.785489e-01 | 0.320 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 4.785489e-01 | 0.320 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 4.788492e-01 | 0.320 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.788492e-01 | 0.320 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 4.807876e-01 | 0.318 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 4.807876e-01 | 0.318 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 4.807876e-01 | 0.318 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 4.807876e-01 | 0.318 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 4.807876e-01 | 0.318 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.827085e-01 | 0.316 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.827085e-01 | 0.316 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.827085e-01 | 0.316 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.827085e-01 | 0.316 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.827085e-01 | 0.316 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.827085e-01 | 0.316 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 4.840157e-01 | 0.315 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 4.840157e-01 | 0.315 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 4.840157e-01 | 0.315 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 4.840157e-01 | 0.315 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 4.840157e-01 | 0.315 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 4.840157e-01 | 0.315 | 0 | 0 |
| SLC-mediated transport of oligopeptides | R-HSA-9959399 | 4.840157e-01 | 0.315 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 4.840157e-01 | 0.315 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.892386e-01 | 0.310 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 4.943649e-01 | 0.306 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 4.943649e-01 | 0.306 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 4.958924e-01 | 0.305 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.973435e-01 | 0.303 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.973435e-01 | 0.303 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.973435e-01 | 0.303 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 4.981860e-01 | 0.303 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 5.006355e-01 | 0.300 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 5.007094e-01 | 0.300 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 5.040934e-01 | 0.297 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.045994e-01 | 0.297 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 5.045994e-01 | 0.297 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.061142e-01 | 0.296 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 5.092364e-01 | 0.293 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 5.092364e-01 | 0.293 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.128652e-01 | 0.290 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 5.148579e-01 | 0.288 | 0 | 0 |
| PKA activation | R-HSA-163615 | 5.150164e-01 | 0.288 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 5.150164e-01 | 0.288 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 5.151700e-01 | 0.288 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 5.164575e-01 | 0.287 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 5.207772e-01 | 0.283 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 5.207772e-01 | 0.283 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 5.207772e-01 | 0.283 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 5.227405e-01 | 0.282 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.227405e-01 | 0.282 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.316599e-01 | 0.274 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 5.343849e-01 | 0.272 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 5.343849e-01 | 0.272 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 5.343849e-01 | 0.272 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 5.343849e-01 | 0.272 | 0 | 0 |
| RSK activation | R-HSA-444257 | 5.343849e-01 | 0.272 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 5.374492e-01 | 0.270 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.463080e-01 | 0.263 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 5.479473e-01 | 0.261 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 5.481587e-01 | 0.261 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 5.481587e-01 | 0.261 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 5.491465e-01 | 0.260 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 5.537142e-01 | 0.257 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 5.568956e-01 | 0.254 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 5.568956e-01 | 0.254 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 5.568956e-01 | 0.254 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 5.568956e-01 | 0.254 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 5.568956e-01 | 0.254 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 5.568956e-01 | 0.254 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 5.568956e-01 | 0.254 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 5.568956e-01 | 0.254 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 5.568956e-01 | 0.254 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 5.568956e-01 | 0.254 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.568956e-01 | 0.254 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 5.568956e-01 | 0.254 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 5.580828e-01 | 0.253 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 5.608172e-01 | 0.251 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.610108e-01 | 0.251 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 5.610108e-01 | 0.251 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 5.651132e-01 | 0.248 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.676612e-01 | 0.246 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 5.680830e-01 | 0.246 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 5.737297e-01 | 0.241 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 5.743174e-01 | 0.241 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 5.800746e-01 | 0.237 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 5.800746e-01 | 0.237 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 5.812705e-01 | 0.236 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 5.812705e-01 | 0.236 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 5.812705e-01 | 0.236 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 5.812705e-01 | 0.236 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 5.812705e-01 | 0.236 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 5.812705e-01 | 0.236 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 5.812705e-01 | 0.236 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 5.812705e-01 | 0.236 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 5.812705e-01 | 0.236 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 5.812705e-01 | 0.236 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 5.812705e-01 | 0.236 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 5.812705e-01 | 0.236 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 5.865116e-01 | 0.232 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 5.920684e-01 | 0.228 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 5.921549e-01 | 0.228 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 5.954958e-01 | 0.225 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 5.973576e-01 | 0.224 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.973576e-01 | 0.224 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 5.973576e-01 | 0.224 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 5.973576e-01 | 0.224 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 5.973576e-01 | 0.224 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.973576e-01 | 0.224 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.973576e-01 | 0.224 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 5.974870e-01 | 0.224 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 5.982039e-01 | 0.223 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.011192e-01 | 0.221 | 0 | 0 |
| Immune System | R-HSA-168256 | 6.017771e-01 | 0.221 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 6.020434e-01 | 0.220 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 6.049900e-01 | 0.218 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 6.087008e-01 | 0.216 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 6.087008e-01 | 0.216 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 6.100068e-01 | 0.215 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.106558e-01 | 0.214 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 6.106558e-01 | 0.214 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.125682e-01 | 0.213 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 6.203815e-01 | 0.207 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 6.203815e-01 | 0.207 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 6.203815e-01 | 0.207 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 6.211282e-01 | 0.207 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 6.211282e-01 | 0.207 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.222959e-01 | 0.206 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.230674e-01 | 0.205 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 6.234748e-01 | 0.205 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 6.234748e-01 | 0.205 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 6.234748e-01 | 0.205 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 6.234748e-01 | 0.205 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 6.234748e-01 | 0.205 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 6.234748e-01 | 0.205 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 6.234748e-01 | 0.205 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 6.234748e-01 | 0.205 | 0 | 0 |
| Transmission across Electrical Synapses | R-HSA-112307 | 6.234748e-01 | 0.205 | 0 | 0 |
| Electric Transmission Across Gap Junctions | R-HSA-112303 | 6.234748e-01 | 0.205 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 6.234748e-01 | 0.205 | 0 | 0 |
| Toxicity of tetanus toxin (tetX) | R-HSA-5250982 | 6.234748e-01 | 0.205 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.245823e-01 | 0.204 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 6.245823e-01 | 0.204 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 6.245823e-01 | 0.204 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 6.245823e-01 | 0.204 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 6.245823e-01 | 0.204 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 6.245823e-01 | 0.204 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 6.245823e-01 | 0.204 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 6.245823e-01 | 0.204 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 6.309318e-01 | 0.200 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 6.309318e-01 | 0.200 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 6.309318e-01 | 0.200 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.316757e-01 | 0.200 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 6.316757e-01 | 0.200 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 6.316757e-01 | 0.200 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 6.316757e-01 | 0.200 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 6.316757e-01 | 0.200 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 6.316757e-01 | 0.200 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 6.316757e-01 | 0.200 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 6.316757e-01 | 0.200 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 6.327237e-01 | 0.199 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 6.327237e-01 | 0.199 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 6.327691e-01 | 0.199 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 6.359009e-01 | 0.197 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 6.398227e-01 | 0.194 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 6.398227e-01 | 0.194 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 6.406003e-01 | 0.193 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.406003e-01 | 0.193 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.407176e-01 | 0.193 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 6.418484e-01 | 0.193 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 6.423523e-01 | 0.192 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 6.423523e-01 | 0.192 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.495555e-01 | 0.187 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 6.503511e-01 | 0.187 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 6.512238e-01 | 0.186 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.559451e-01 | 0.183 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 6.639078e-01 | 0.178 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 6.639078e-01 | 0.178 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 6.639078e-01 | 0.178 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.639078e-01 | 0.178 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 6.643357e-01 | 0.178 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 6.643357e-01 | 0.178 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 6.643357e-01 | 0.178 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 6.643357e-01 | 0.178 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 6.643357e-01 | 0.178 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 6.643357e-01 | 0.178 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 6.675218e-01 | 0.176 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.675218e-01 | 0.176 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 6.675218e-01 | 0.176 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.725808e-01 | 0.172 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 6.725808e-01 | 0.172 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 6.751795e-01 | 0.171 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 6.751795e-01 | 0.171 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 6.751795e-01 | 0.171 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 6.781939e-01 | 0.169 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.797117e-01 | 0.168 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 6.800532e-01 | 0.167 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 6.800532e-01 | 0.167 | 0 | 0 |
| FGFR1c and Klotho ligand binding and activation | R-HSA-190374 | 6.800532e-01 | 0.167 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 6.800532e-01 | 0.167 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 6.800532e-01 | 0.167 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 6.800532e-01 | 0.167 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 6.800532e-01 | 0.167 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 6.800532e-01 | 0.167 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 6.800532e-01 | 0.167 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 6.800532e-01 | 0.167 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 6.800532e-01 | 0.167 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 6.800532e-01 | 0.167 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 6.800532e-01 | 0.167 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 6.800532e-01 | 0.167 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.839905e-01 | 0.165 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 6.839905e-01 | 0.165 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 6.839905e-01 | 0.165 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 6.848660e-01 | 0.164 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 6.908925e-01 | 0.161 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 6.929257e-01 | 0.159 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 6.937225e-01 | 0.159 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 6.937225e-01 | 0.159 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 6.937225e-01 | 0.159 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 6.940363e-01 | 0.159 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.940363e-01 | 0.159 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.940363e-01 | 0.159 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 6.940363e-01 | 0.159 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 6.970326e-01 | 0.157 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 6.970326e-01 | 0.157 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 6.975533e-01 | 0.156 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.006220e-01 | 0.155 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 7.006220e-01 | 0.155 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 7.006220e-01 | 0.155 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 7.006220e-01 | 0.155 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 7.006220e-01 | 0.155 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.006220e-01 | 0.155 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 7.006220e-01 | 0.155 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.011529e-01 | 0.154 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 7.119764e-01 | 0.148 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 7.126186e-01 | 0.147 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.164807e-01 | 0.145 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 7.182255e-01 | 0.144 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 7.184140e-01 | 0.144 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 7.193975e-01 | 0.143 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 7.196464e-01 | 0.143 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 7.220764e-01 | 0.141 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 7.220764e-01 | 0.141 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 7.220764e-01 | 0.141 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 7.264508e-01 | 0.139 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 7.281327e-01 | 0.138 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 7.281327e-01 | 0.138 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 7.281327e-01 | 0.138 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 7.281327e-01 | 0.138 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 7.281327e-01 | 0.138 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 7.281327e-01 | 0.138 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 7.281327e-01 | 0.138 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 7.281327e-01 | 0.138 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 7.281327e-01 | 0.138 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 7.281327e-01 | 0.138 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 7.281327e-01 | 0.138 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 7.281327e-01 | 0.138 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 7.281327e-01 | 0.138 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 7.281327e-01 | 0.138 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 7.335855e-01 | 0.135 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 7.335855e-01 | 0.135 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.335855e-01 | 0.135 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.392750e-01 | 0.131 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 7.404490e-01 | 0.131 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.416030e-01 | 0.130 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.416030e-01 | 0.130 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.416030e-01 | 0.130 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 7.423683e-01 | 0.129 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 7.463732e-01 | 0.127 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 7.480695e-01 | 0.126 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.480695e-01 | 0.126 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 7.480695e-01 | 0.126 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 7.572398e-01 | 0.121 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 7.575012e-01 | 0.121 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 7.591473e-01 | 0.120 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 7.613065e-01 | 0.118 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 7.633105e-01 | 0.117 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.633105e-01 | 0.117 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.633105e-01 | 0.117 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 7.634053e-01 | 0.117 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 7.634053e-01 | 0.117 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 7.634053e-01 | 0.117 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 7.634053e-01 | 0.117 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 7.634053e-01 | 0.117 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 7.689894e-01 | 0.114 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 7.689894e-01 | 0.114 | 0 | 0 |
| Defective B4GALT1 causes B4GALT1-CDG (CDG-2d) | R-HSA-3656244 | 7.689894e-01 | 0.114 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 7.689894e-01 | 0.114 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 7.689894e-01 | 0.114 | 0 | 0 |
| Defective CHST6 causes MCDC1 | R-HSA-3656225 | 7.689894e-01 | 0.114 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 7.689894e-01 | 0.114 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 7.689894e-01 | 0.114 | 0 | 0 |
| Defective ST3GAL3 causes MCT12 and EIEE15 | R-HSA-3656243 | 7.689894e-01 | 0.114 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 7.689894e-01 | 0.114 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 7.689894e-01 | 0.114 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 7.689894e-01 | 0.114 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 7.689894e-01 | 0.114 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 7.689894e-01 | 0.114 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 7.695261e-01 | 0.114 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 7.737943e-01 | 0.111 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.749575e-01 | 0.111 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.749575e-01 | 0.111 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 7.749575e-01 | 0.111 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.778574e-01 | 0.109 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 7.835695e-01 | 0.106 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 7.835695e-01 | 0.106 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 7.835695e-01 | 0.106 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 7.835695e-01 | 0.106 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 7.840462e-01 | 0.106 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 7.902816e-01 | 0.102 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 7.902816e-01 | 0.102 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 7.902816e-01 | 0.102 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.915188e-01 | 0.102 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.915188e-01 | 0.102 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 7.941782e-01 | 0.100 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.941782e-01 | 0.100 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.941782e-01 | 0.100 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.941782e-01 | 0.100 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 7.954280e-01 | 0.099 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 7.954280e-01 | 0.099 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 8.014845e-01 | 0.096 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 8.016804e-01 | 0.096 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 8.024228e-01 | 0.096 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 8.024228e-01 | 0.096 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.024228e-01 | 0.096 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 8.037081e-01 | 0.095 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 8.037081e-01 | 0.095 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 8.037081e-01 | 0.095 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 8.037081e-01 | 0.095 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 8.037081e-01 | 0.095 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 8.037081e-01 | 0.095 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 8.037081e-01 | 0.095 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 8.037081e-01 | 0.095 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 8.037081e-01 | 0.095 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 8.037081e-01 | 0.095 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 8.037081e-01 | 0.095 | 0 | 0 |
| Opsins | R-HSA-419771 | 8.037081e-01 | 0.095 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 8.037081e-01 | 0.095 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 8.037081e-01 | 0.095 | 0 | 0 |
| Biosynthesis of maresin conjugates in tissue regeneration (MCTR) | R-HSA-9026762 | 8.037081e-01 | 0.095 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 8.037081e-01 | 0.095 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.069256e-01 | 0.093 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.096240e-01 | 0.092 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.118882e-01 | 0.091 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 8.118882e-01 | 0.091 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 8.144257e-01 | 0.089 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.144257e-01 | 0.089 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.144257e-01 | 0.089 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.144257e-01 | 0.089 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 8.144257e-01 | 0.089 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.144257e-01 | 0.089 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 8.144600e-01 | 0.089 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 8.144600e-01 | 0.089 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 8.144600e-01 | 0.089 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.151058e-01 | 0.089 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 8.178291e-01 | 0.087 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.215251e-01 | 0.085 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.248801e-01 | 0.084 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 8.262871e-01 | 0.083 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 8.330196e-01 | 0.079 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 8.330196e-01 | 0.079 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 8.332106e-01 | 0.079 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 8.332106e-01 | 0.079 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 8.332106e-01 | 0.079 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 8.332106e-01 | 0.079 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 8.332106e-01 | 0.079 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 8.332106e-01 | 0.079 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 8.332106e-01 | 0.079 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 8.332106e-01 | 0.079 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 8.332106e-01 | 0.079 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 8.332106e-01 | 0.079 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 8.332106e-01 | 0.079 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 8.332106e-01 | 0.079 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 8.332106e-01 | 0.079 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 8.332106e-01 | 0.079 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 8.332106e-01 | 0.079 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 8.332106e-01 | 0.079 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 8.332106e-01 | 0.079 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 8.332106e-01 | 0.079 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.360514e-01 | 0.078 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.360514e-01 | 0.078 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.360514e-01 | 0.078 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.360514e-01 | 0.078 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.360514e-01 | 0.078 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.361201e-01 | 0.078 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 8.362391e-01 | 0.078 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 8.379486e-01 | 0.077 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 8.446304e-01 | 0.073 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 8.462316e-01 | 0.073 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 8.462316e-01 | 0.073 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 8.499581e-01 | 0.071 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 8.499581e-01 | 0.071 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 8.510811e-01 | 0.070 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.510811e-01 | 0.070 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 8.511264e-01 | 0.070 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.511264e-01 | 0.070 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 8.537018e-01 | 0.069 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.549682e-01 | 0.068 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.553704e-01 | 0.068 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 8.553704e-01 | 0.068 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 8.582804e-01 | 0.066 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 8.582804e-01 | 0.066 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 8.582804e-01 | 0.066 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 8.582804e-01 | 0.066 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 8.582804e-01 | 0.066 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 8.582804e-01 | 0.066 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 8.582804e-01 | 0.066 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 8.582804e-01 | 0.066 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.601029e-01 | 0.065 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.648671e-01 | 0.063 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 8.653788e-01 | 0.063 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.653788e-01 | 0.063 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.653788e-01 | 0.063 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.653788e-01 | 0.063 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 8.653788e-01 | 0.063 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.711754e-01 | 0.060 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.713156e-01 | 0.060 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.713255e-01 | 0.060 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.713255e-01 | 0.060 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 8.725873e-01 | 0.059 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.725873e-01 | 0.059 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.727899e-01 | 0.059 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.759972e-01 | 0.057 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 8.766056e-01 | 0.057 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 8.766056e-01 | 0.057 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 8.775434e-01 | 0.057 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 8.788569e-01 | 0.056 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.788569e-01 | 0.056 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.793854e-01 | 0.056 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 8.793854e-01 | 0.056 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 8.793854e-01 | 0.056 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 8.793854e-01 | 0.056 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.793854e-01 | 0.056 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 8.793854e-01 | 0.056 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 8.795831e-01 | 0.056 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 8.795831e-01 | 0.056 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 8.795831e-01 | 0.056 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.795831e-01 | 0.056 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 8.795831e-01 | 0.056 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 8.795831e-01 | 0.056 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 8.795831e-01 | 0.056 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.795831e-01 | 0.056 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.860721e-01 | 0.053 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 8.878976e-01 | 0.052 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 8.878976e-01 | 0.052 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 8.878976e-01 | 0.052 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.891754e-01 | 0.051 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 8.911279e-01 | 0.050 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.920801e-01 | 0.050 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.920801e-01 | 0.050 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 8.976848e-01 | 0.047 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 8.976848e-01 | 0.047 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 8.976848e-01 | 0.047 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.976848e-01 | 0.047 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 8.976848e-01 | 0.047 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 8.976848e-01 | 0.047 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 8.976848e-01 | 0.047 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 8.976848e-01 | 0.047 | 0 | 0 |
| Vitamin B1 (thiamin) metabolism | R-HSA-196819 | 8.976848e-01 | 0.047 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.976848e-01 | 0.047 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 8.976848e-01 | 0.047 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 8.976848e-01 | 0.047 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.014852e-01 | 0.045 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 9.014852e-01 | 0.045 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.014852e-01 | 0.045 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.035624e-01 | 0.044 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.073280e-01 | 0.042 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.089489e-01 | 0.041 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.103960e-01 | 0.041 | 0 | 0 |
| Scavenging by Class H Receptors | R-HSA-3000497 | 9.130662e-01 | 0.039 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 9.130662e-01 | 0.039 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 9.130662e-01 | 0.039 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 9.130662e-01 | 0.039 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 9.130662e-01 | 0.039 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 9.130662e-01 | 0.039 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 9.130662e-01 | 0.039 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.135220e-01 | 0.039 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.135220e-01 | 0.039 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 9.135220e-01 | 0.039 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.139283e-01 | 0.039 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.184549e-01 | 0.037 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.184549e-01 | 0.037 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 9.191947e-01 | 0.037 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.194528e-01 | 0.036 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.198693e-01 | 0.036 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.232696e-01 | 0.035 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.232696e-01 | 0.035 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.238991e-01 | 0.034 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 9.238991e-01 | 0.034 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.246002e-01 | 0.034 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.246013e-01 | 0.034 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 9.261360e-01 | 0.033 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 9.261360e-01 | 0.033 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 9.261360e-01 | 0.033 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 9.261360e-01 | 0.033 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 9.261360e-01 | 0.033 | 0 | 0 |
| Proline catabolism | R-HSA-70688 | 9.261360e-01 | 0.033 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 9.261360e-01 | 0.033 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 9.261360e-01 | 0.033 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 9.261360e-01 | 0.033 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 9.261360e-01 | 0.033 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 9.261360e-01 | 0.033 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 9.261360e-01 | 0.033 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 9.261360e-01 | 0.033 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 9.261360e-01 | 0.033 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.313664e-01 | 0.031 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.316734e-01 | 0.031 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.316734e-01 | 0.031 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.316734e-01 | 0.031 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 9.321629e-01 | 0.031 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.335670e-01 | 0.030 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.345317e-01 | 0.029 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 9.372415e-01 | 0.028 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 9.372415e-01 | 0.028 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 9.372415e-01 | 0.028 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 9.372415e-01 | 0.028 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 9.372415e-01 | 0.028 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 9.378021e-01 | 0.028 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.406051e-01 | 0.027 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.406051e-01 | 0.027 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.406051e-01 | 0.027 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.406051e-01 | 0.027 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.415038e-01 | 0.026 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.418552e-01 | 0.026 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.418552e-01 | 0.026 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.418552e-01 | 0.026 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.418552e-01 | 0.026 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.422817e-01 | 0.026 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.422864e-01 | 0.026 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.459912e-01 | 0.024 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.459912e-01 | 0.024 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 9.466709e-01 | 0.024 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 9.466778e-01 | 0.024 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 9.466778e-01 | 0.024 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 9.466778e-01 | 0.024 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 9.466778e-01 | 0.024 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 9.466778e-01 | 0.024 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 9.466778e-01 | 0.024 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.466778e-01 | 0.024 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 9.466778e-01 | 0.024 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.476838e-01 | 0.023 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.490047e-01 | 0.023 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.490702e-01 | 0.023 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.490702e-01 | 0.023 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.491535e-01 | 0.023 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.491535e-01 | 0.023 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.491535e-01 | 0.023 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.491535e-01 | 0.023 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.500467e-01 | 0.022 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.525168e-01 | 0.021 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 9.546958e-01 | 0.020 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 9.546958e-01 | 0.020 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.555722e-01 | 0.020 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.555722e-01 | 0.020 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.565885e-01 | 0.019 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.571323e-01 | 0.019 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.574757e-01 | 0.019 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.574757e-01 | 0.019 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.605901e-01 | 0.017 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.612107e-01 | 0.017 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.612107e-01 | 0.017 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.612107e-01 | 0.017 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.614031e-01 | 0.017 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 9.615085e-01 | 0.017 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 9.615085e-01 | 0.017 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.615085e-01 | 0.017 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 9.615085e-01 | 0.017 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.615085e-01 | 0.017 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 9.615085e-01 | 0.017 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.623184e-01 | 0.017 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 9.623184e-01 | 0.017 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.623184e-01 | 0.017 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.623184e-01 | 0.017 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.651916e-01 | 0.015 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.657298e-01 | 0.015 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.661585e-01 | 0.015 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.662730e-01 | 0.015 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.666386e-01 | 0.015 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.666386e-01 | 0.015 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 9.672970e-01 | 0.014 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 9.672970e-01 | 0.014 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 9.672970e-01 | 0.014 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 9.672970e-01 | 0.014 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 9.672970e-01 | 0.014 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 9.672970e-01 | 0.014 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 9.672970e-01 | 0.014 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 9.672970e-01 | 0.014 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 9.672970e-01 | 0.014 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.672970e-01 | 0.014 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.683500e-01 | 0.014 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.683500e-01 | 0.014 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.689376e-01 | 0.014 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.693153e-01 | 0.014 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.693153e-01 | 0.014 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.695898e-01 | 0.013 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.704880e-01 | 0.013 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.704880e-01 | 0.013 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.704958e-01 | 0.013 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 9.704958e-01 | 0.013 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 9.722154e-01 | 0.012 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.722154e-01 | 0.012 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.734056e-01 | 0.012 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.735202e-01 | 0.012 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.743786e-01 | 0.011 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.754032e-01 | 0.011 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.755496e-01 | 0.011 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 9.756467e-01 | 0.011 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.763942e-01 | 0.010 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.763942e-01 | 0.010 | 0 | 0 |
| Biosynthesis of DHA-derived sulfido conjugates | R-HSA-9026395 | 9.763942e-01 | 0.010 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 9.763942e-01 | 0.010 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.769603e-01 | 0.010 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.773472e-01 | 0.010 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.776178e-01 | 0.010 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.776178e-01 | 0.010 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.779048e-01 | 0.010 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.790099e-01 | 0.009 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.791583e-01 | 0.009 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.796658e-01 | 0.009 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 9.799448e-01 | 0.009 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.799448e-01 | 0.009 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.799448e-01 | 0.009 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.799448e-01 | 0.009 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.799448e-01 | 0.009 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.799448e-01 | 0.009 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.799448e-01 | 0.009 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.799448e-01 | 0.009 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.801670e-01 | 0.009 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.823357e-01 | 0.008 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.823357e-01 | 0.008 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.829615e-01 | 0.007 | 0 | 0 |
| Keratan sulfate degradation | R-HSA-2022857 | 9.829615e-01 | 0.007 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.829615e-01 | 0.007 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.829615e-01 | 0.007 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.829615e-01 | 0.007 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.829615e-01 | 0.007 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.830614e-01 | 0.007 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.838263e-01 | 0.007 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.840554e-01 | 0.007 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.840554e-01 | 0.007 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.841947e-01 | 0.007 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.846182e-01 | 0.007 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.849980e-01 | 0.007 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.855246e-01 | 0.006 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.855246e-01 | 0.006 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.855246e-01 | 0.006 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.855246e-01 | 0.006 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.855246e-01 | 0.006 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.855246e-01 | 0.006 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.855246e-01 | 0.006 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.855246e-01 | 0.006 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.857188e-01 | 0.006 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.857188e-01 | 0.006 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.857188e-01 | 0.006 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.858372e-01 | 0.006 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.863256e-01 | 0.006 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.870829e-01 | 0.006 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.872174e-01 | 0.006 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.877022e-01 | 0.005 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.877022e-01 | 0.005 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.877022e-01 | 0.005 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.877022e-01 | 0.005 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.877022e-01 | 0.005 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.877022e-01 | 0.005 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.877476e-01 | 0.005 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.877476e-01 | 0.005 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.877476e-01 | 0.005 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.885183e-01 | 0.005 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.891589e-01 | 0.005 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.893560e-01 | 0.005 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.895524e-01 | 0.005 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.895524e-01 | 0.005 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.895524e-01 | 0.005 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.895524e-01 | 0.005 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.895524e-01 | 0.005 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.895524e-01 | 0.005 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.903606e-01 | 0.004 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.903606e-01 | 0.004 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.911242e-01 | 0.004 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.911242e-01 | 0.004 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.915679e-01 | 0.004 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.919441e-01 | 0.004 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.924597e-01 | 0.003 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.924597e-01 | 0.003 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.924686e-01 | 0.003 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.927278e-01 | 0.003 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.927489e-01 | 0.003 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.927489e-01 | 0.003 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.928802e-01 | 0.003 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.928802e-01 | 0.003 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.933408e-01 | 0.003 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.935943e-01 | 0.003 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.937151e-01 | 0.003 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.937151e-01 | 0.003 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.937151e-01 | 0.003 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.937151e-01 | 0.003 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.937151e-01 | 0.003 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.938902e-01 | 0.003 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.945582e-01 | 0.002 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.945582e-01 | 0.002 | 0 | 0 |
| Linoleic acid (LA) metabolism | R-HSA-2046105 | 9.945582e-01 | 0.002 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.945582e-01 | 0.002 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.945582e-01 | 0.002 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.949680e-01 | 0.002 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.952925e-01 | 0.002 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.953772e-01 | 0.002 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.953772e-01 | 0.002 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.953772e-01 | 0.002 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.953772e-01 | 0.002 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.954567e-01 | 0.002 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.954879e-01 | 0.002 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.959239e-01 | 0.002 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.960729e-01 | 0.002 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.960729e-01 | 0.002 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.960729e-01 | 0.002 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.960729e-01 | 0.002 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.960932e-01 | 0.002 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.962248e-01 | 0.002 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.963573e-01 | 0.002 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.964667e-01 | 0.002 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.964667e-01 | 0.002 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.964667e-01 | 0.002 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.966639e-01 | 0.001 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.967788e-01 | 0.001 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.969898e-01 | 0.001 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.970999e-01 | 0.001 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.971661e-01 | 0.001 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.971973e-01 | 0.001 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.973565e-01 | 0.001 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.973565e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.978856e-01 | 0.001 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.979550e-01 | 0.001 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.979550e-01 | 0.001 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.979777e-01 | 0.001 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.981054e-01 | 0.001 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.982272e-01 | 0.001 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.982629e-01 | 0.001 | 0 | 0 |
| Keratan sulfate biosynthesis | R-HSA-2022854 | 9.982629e-01 | 0.001 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.982629e-01 | 0.001 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.982934e-01 | 0.001 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.983048e-01 | 0.001 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.984831e-01 | 0.001 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.985189e-01 | 0.001 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.985244e-01 | 0.001 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.987466e-01 | 0.001 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.987466e-01 | 0.001 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.987466e-01 | 0.001 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.988742e-01 | 0.000 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.988742e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.988742e-01 | 0.000 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.988920e-01 | 0.000 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.989012e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.989284e-01 | 0.000 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.989353e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.990180e-01 | 0.000 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.990517e-01 | 0.000 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.990956e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.991283e-01 | 0.000 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.991357e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.991438e-01 | 0.000 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.991789e-01 | 0.000 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.992318e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.992943e-01 | 0.000 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.993087e-01 | 0.000 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.993475e-01 | 0.000 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.993475e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.993498e-01 | 0.000 | 0 | 0 |
| Diseases associated with N-glycosylation of proteins | R-HSA-3781860 | 9.994457e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.994736e-01 | 0.000 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.995292e-01 | 0.000 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.995292e-01 | 0.000 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.995477e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.995921e-01 | 0.000 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.996001e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.996265e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.996265e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.996427e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.996604e-01 | 0.000 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.996604e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.996965e-01 | 0.000 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.997115e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.997476e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.997543e-01 | 0.000 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.997550e-01 | 0.000 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.997550e-01 | 0.000 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.997550e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.997855e-01 | 0.000 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.997919e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.997923e-01 | 0.000 | 0 | 0 |
| The canonical retinoid cycle in rods (twilight vision) | R-HSA-2453902 | 9.998232e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.998411e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.998411e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.998654e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.998682e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.998712e-01 | 0.000 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.998725e-01 | 0.000 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.998725e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.998917e-01 | 0.000 | 0 | 0 |
| Keratan sulfate/keratin metabolism | R-HSA-1638074 | 9.999080e-01 | 0.000 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.999080e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.999219e-01 | 0.000 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.999337e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.999356e-01 | 0.000 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.999480e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.999591e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.999649e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.999649e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.999707e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999739e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999741e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.999747e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.999777e-01 | 0.000 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.999848e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999867e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.999879e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.999896e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.999907e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999924e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999924e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999957e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999959e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.999967e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999970e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.999970e-01 | 0.000 | 0 | 0 |
| Classical antibody-mediated complement activation | R-HSA-173623 | 9.999978e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999979e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.999979e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999984e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.999987e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999988e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999992e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.999994e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999994e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999995e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999996e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999997e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999997e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999997e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999997e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999997e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999998e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999999e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999999e-01 | 0.000 | 0 | 0 |
| Creation of C4 and C2 activators | R-HSA-166786 | 9.999999e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999999e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 3.330669e-16 | 15.477 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.330669e-15 | 14.477 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 5.329071e-15 | 14.273 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.232348e-14 | 13.909 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.509903e-14 | 13.821 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 8.426593e-14 | 13.074 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.102762e-13 | 12.677 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 4.251044e-13 | 12.372 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.665890e-12 | 11.778 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.951328e-12 | 11.710 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.107314e-12 | 11.676 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.356559e-12 | 11.628 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.733258e-12 | 11.563 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.235001e-11 | 10.651 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.569543e-10 | 9.804 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.139049e-10 | 9.670 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.307381e-10 | 9.637 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.553603e-10 | 9.449 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 5.422436e-10 | 9.266 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 5.950497e-10 | 9.225 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 7.900113e-10 | 9.102 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 8.585316e-10 | 9.066 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 9.122889e-10 | 9.040 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.147146e-09 | 8.940 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.976955e-09 | 8.704 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.305141e-09 | 8.637 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.245387e-09 | 8.489 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.073913e-09 | 8.390 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 5.287668e-09 | 8.277 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.225777e-09 | 8.141 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 8.298722e-09 | 8.081 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.534037e-08 | 7.596 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.655863e-08 | 7.576 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.425353e-08 | 7.465 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 3.813302e-08 | 7.419 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 5.216004e-08 | 7.283 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 5.603301e-08 | 7.252 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.232591e-08 | 7.205 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 8.514535e-08 | 7.070 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.231977e-08 | 7.035 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.206458e-07 | 6.918 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.286691e-07 | 6.891 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.521169e-07 | 6.818 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.521169e-07 | 6.818 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.533698e-07 | 6.814 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.965047e-07 | 6.528 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.137940e-07 | 6.503 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.137940e-07 | 6.503 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 4.220482e-07 | 6.375 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 4.130684e-07 | 6.384 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.502191e-07 | 6.347 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.280192e-07 | 6.032 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 9.659000e-07 | 6.015 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 9.902883e-07 | 6.004 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.034189e-06 | 5.985 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.264651e-06 | 5.898 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.307253e-06 | 5.884 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.445884e-06 | 5.840 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.408124e-06 | 5.851 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.894286e-06 | 5.723 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.047965e-06 | 5.689 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.146020e-06 | 5.668 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.325312e-06 | 5.634 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.597400e-06 | 5.585 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.905367e-06 | 5.537 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.053844e-06 | 5.515 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 3.581049e-06 | 5.446 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.617240e-06 | 5.442 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.617240e-06 | 5.442 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 4.198165e-06 | 5.377 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.269939e-06 | 5.370 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 4.744388e-06 | 5.324 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 7.129618e-06 | 5.147 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 8.268973e-06 | 5.083 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 8.268973e-06 | 5.083 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 9.082907e-06 | 5.042 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 9.795975e-06 | 5.009 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.022338e-05 | 4.990 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.098458e-05 | 4.959 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.143439e-05 | 4.942 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.228318e-05 | 4.911 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.512513e-05 | 4.820 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.532599e-05 | 4.815 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.997969e-05 | 4.699 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.970036e-05 | 4.706 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.198070e-05 | 4.658 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.253108e-05 | 4.647 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.284829e-05 | 4.641 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.380318e-05 | 4.623 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.577397e-05 | 4.589 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.066482e-05 | 4.513 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.167981e-05 | 4.499 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.167981e-05 | 4.499 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.284983e-05 | 4.483 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.677260e-05 | 4.434 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 4.280975e-05 | 4.368 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.769349e-05 | 4.239 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 5.829048e-05 | 4.234 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.605651e-05 | 4.180 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 6.357995e-05 | 4.197 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 6.605677e-05 | 4.180 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 7.000205e-05 | 4.155 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 7.035629e-05 | 4.153 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 7.395575e-05 | 4.131 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 7.622335e-05 | 4.118 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 8.851971e-05 | 4.053 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 8.851971e-05 | 4.053 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.383598e-05 | 4.077 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 8.356556e-05 | 4.078 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 8.979105e-05 | 4.047 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.000257e-04 | 4.000 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.038791e-04 | 3.983 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.042246e-04 | 3.982 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.077086e-04 | 3.968 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.178580e-04 | 3.929 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.498445e-04 | 3.824 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.511239e-04 | 3.821 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.649643e-04 | 3.783 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.766862e-04 | 3.753 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.818665e-04 | 3.740 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.698402e-04 | 3.770 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.748672e-04 | 3.757 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.765992e-04 | 3.753 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.822848e-04 | 3.739 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.843885e-04 | 3.734 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.844604e-04 | 3.734 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.882580e-04 | 3.725 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.085234e-04 | 3.681 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 2.202481e-04 | 3.657 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.255037e-04 | 3.647 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.282472e-04 | 3.642 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.452452e-04 | 3.610 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 2.610872e-04 | 3.583 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.610872e-04 | 3.583 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.616902e-04 | 3.582 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.616902e-04 | 3.582 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.616902e-04 | 3.582 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.814786e-04 | 3.551 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.021672e-04 | 3.520 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.002636e-04 | 3.522 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.002636e-04 | 3.522 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.986955e-04 | 3.525 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 3.275004e-04 | 3.485 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 3.275004e-04 | 3.485 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 3.275004e-04 | 3.485 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 3.275004e-04 | 3.485 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.506139e-04 | 3.455 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 3.553857e-04 | 3.449 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 3.589927e-04 | 3.445 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.698587e-04 | 3.432 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.840455e-04 | 3.416 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.941877e-04 | 3.404 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 3.984801e-04 | 3.400 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.085173e-04 | 3.389 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 4.706390e-04 | 3.327 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 4.965173e-04 | 3.304 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.074199e-04 | 3.295 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.074199e-04 | 3.295 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.376305e-04 | 3.270 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 5.812712e-04 | 3.236 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 5.904784e-04 | 3.229 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 6.148128e-04 | 3.211 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 6.213010e-04 | 3.207 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 6.428509e-04 | 3.192 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 6.428509e-04 | 3.192 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 6.482834e-04 | 3.188 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 6.482834e-04 | 3.188 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 6.482834e-04 | 3.188 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 7.132238e-04 | 3.147 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 7.394056e-04 | 3.131 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 7.132238e-04 | 3.147 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 7.317514e-04 | 3.136 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 8.160496e-04 | 3.088 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.602590e-04 | 3.065 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 8.602590e-04 | 3.065 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 8.720665e-04 | 3.059 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 8.720665e-04 | 3.059 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 8.720665e-04 | 3.059 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 9.883061e-04 | 3.005 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 9.883061e-04 | 3.005 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 9.883061e-04 | 3.005 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 9.883061e-04 | 3.005 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 9.883061e-04 | 3.005 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 9.883061e-04 | 3.005 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 9.883061e-04 | 3.005 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 9.883061e-04 | 3.005 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 9.883061e-04 | 3.005 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 9.883061e-04 | 3.005 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 9.883061e-04 | 3.005 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.194126e-04 | 3.036 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 8.991036e-04 | 3.046 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 8.905812e-04 | 3.050 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 8.977344e-04 | 3.047 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.718408e-04 | 3.012 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 9.863673e-04 | 3.006 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.292241e-04 | 3.032 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.292241e-04 | 3.032 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.004829e-03 | 2.998 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.004829e-03 | 2.998 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.009751e-03 | 2.996 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 1.048665e-03 | 2.979 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 1.048665e-03 | 2.979 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.081876e-03 | 2.966 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.146346e-03 | 2.941 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.166649e-03 | 2.933 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.183802e-03 | 2.927 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.183802e-03 | 2.927 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.195204e-03 | 2.923 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.195204e-03 | 2.923 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.196216e-03 | 2.922 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.210280e-03 | 2.917 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.257448e-03 | 2.901 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.269024e-03 | 2.897 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.269024e-03 | 2.897 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.340790e-03 | 2.873 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.370407e-03 | 2.863 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.453609e-03 | 2.838 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.360697e-03 | 2.866 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.346200e-03 | 2.871 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.336955e-03 | 2.874 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.303681e-03 | 2.885 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.484010e-03 | 2.829 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.538277e-03 | 2.813 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.542202e-03 | 2.812 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.563311e-03 | 2.806 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.606739e-03 | 2.794 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.765163e-03 | 2.753 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.765778e-03 | 2.753 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.766410e-03 | 2.753 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.766410e-03 | 2.753 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.784218e-03 | 2.749 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.788276e-03 | 2.748 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.814697e-03 | 2.741 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.834235e-03 | 2.737 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.874131e-03 | 2.727 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.878749e-03 | 2.726 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.911621e-03 | 2.719 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.923685e-03 | 2.716 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.947779e-03 | 2.710 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.953388e-03 | 2.709 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.988183e-03 | 2.702 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.063527e-03 | 2.685 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.075530e-03 | 2.683 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.091280e-03 | 2.680 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.214216e-03 | 2.655 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.214216e-03 | 2.655 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.230751e-03 | 2.652 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.321117e-03 | 2.634 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.572136e-03 | 2.590 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.572136e-03 | 2.590 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 2.540137e-03 | 2.595 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.731526e-03 | 2.564 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.540137e-03 | 2.595 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.420996e-03 | 2.616 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 2.685863e-03 | 2.571 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.475284e-03 | 2.606 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.770379e-03 | 2.557 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.790267e-03 | 2.554 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 2.799478e-03 | 2.553 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.925081e-03 | 2.534 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 2.932364e-03 | 2.533 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 3.069589e-03 | 2.513 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.069589e-03 | 2.513 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.108128e-03 | 2.508 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.108128e-03 | 2.508 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.254585e-03 | 2.488 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 3.298824e-03 | 2.482 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.354894e-03 | 2.474 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.456589e-03 | 2.461 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 3.660773e-03 | 2.436 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 3.660773e-03 | 2.436 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 3.660773e-03 | 2.436 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 3.697647e-03 | 2.432 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.801035e-03 | 2.420 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.801035e-03 | 2.420 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.815931e-03 | 2.418 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.905850e-03 | 2.408 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.991423e-03 | 2.399 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.019177e-03 | 2.396 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.809399e-03 | 2.318 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 4.883626e-03 | 2.311 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 4.883626e-03 | 2.311 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 4.894675e-03 | 2.310 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 4.635205e-03 | 2.334 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 4.570655e-03 | 2.340 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 4.936562e-03 | 2.307 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.822926e-03 | 2.317 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.822926e-03 | 2.317 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 4.230153e-03 | 2.374 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 4.385542e-03 | 2.358 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.381863e-03 | 2.358 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 4.894675e-03 | 2.310 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.381863e-03 | 2.358 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.412887e-03 | 2.355 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.345843e-03 | 2.362 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 4.319980e-03 | 2.365 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 4.570655e-03 | 2.340 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.732032e-03 | 2.325 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.085890e-03 | 2.294 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 5.113428e-03 | 2.291 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.160884e-03 | 2.287 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 5.189476e-03 | 2.285 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 5.313724e-03 | 2.275 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 5.459028e-03 | 2.263 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 5.552420e-03 | 2.256 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 5.635869e-03 | 2.249 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 5.790759e-03 | 2.237 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 6.002494e-03 | 2.222 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 6.236383e-03 | 2.205 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 6.252408e-03 | 2.204 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 6.252408e-03 | 2.204 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 6.356200e-03 | 2.197 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 6.437877e-03 | 2.191 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 6.478243e-03 | 2.189 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 6.478243e-03 | 2.189 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 6.520369e-03 | 2.186 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 6.527188e-03 | 2.185 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 6.527188e-03 | 2.185 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 6.575644e-03 | 2.182 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 7.022999e-03 | 2.153 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 7.105520e-03 | 2.148 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.105520e-03 | 2.148 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 7.163142e-03 | 2.145 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.163142e-03 | 2.145 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 7.163142e-03 | 2.145 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 7.213788e-03 | 2.142 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 7.213788e-03 | 2.142 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 7.213788e-03 | 2.142 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 7.502464e-03 | 2.125 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 7.543763e-03 | 2.122 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 7.606564e-03 | 2.119 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 7.640797e-03 | 2.117 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 7.746766e-03 | 2.111 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 7.746766e-03 | 2.111 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 7.754807e-03 | 2.110 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 8.176409e-03 | 2.087 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 8.181514e-03 | 2.087 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 8.224299e-03 | 2.085 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 8.232282e-03 | 2.084 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.007389e-02 | 1.997 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.050601e-02 | 1.979 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.299880e-03 | 2.032 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.054139e-02 | 1.977 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.016350e-02 | 1.993 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 8.873055e-03 | 2.052 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.054139e-02 | 1.977 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.892603e-03 | 2.005 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 9.083542e-03 | 2.042 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.007389e-02 | 1.997 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 9.190244e-03 | 2.037 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 8.821135e-03 | 2.054 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 9.552693e-03 | 2.020 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.036465e-02 | 1.984 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.053917e-02 | 1.977 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.018170e-02 | 1.992 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.024541e-02 | 1.989 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 9.552693e-03 | 2.020 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 9.552693e-03 | 2.020 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.904225e-03 | 2.050 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.066551e-02 | 1.972 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.097796e-02 | 1.959 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.097796e-02 | 1.959 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.114307e-02 | 1.953 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.132737e-02 | 1.946 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 1.132737e-02 | 1.946 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 1.132737e-02 | 1.946 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.159577e-02 | 1.936 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 1.166851e-02 | 1.933 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.166851e-02 | 1.933 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.177130e-02 | 1.929 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.213197e-02 | 1.916 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.260822e-02 | 1.899 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.286771e-02 | 1.890 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.286771e-02 | 1.890 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.327073e-02 | 1.877 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.338489e-02 | 1.873 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.379701e-02 | 1.860 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 1.379701e-02 | 1.860 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.391103e-02 | 1.857 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.398439e-02 | 1.854 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.411053e-02 | 1.850 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.417273e-02 | 1.849 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.417273e-02 | 1.849 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.429611e-02 | 1.845 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.434881e-02 | 1.843 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.434881e-02 | 1.843 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 1.434881e-02 | 1.843 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.439171e-02 | 1.842 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 1.439351e-02 | 1.842 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.452394e-02 | 1.838 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.524975e-02 | 1.817 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.599257e-02 | 1.796 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.605996e-02 | 1.794 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.618665e-02 | 1.791 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 1.670658e-02 | 1.777 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.670658e-02 | 1.777 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.690485e-02 | 1.772 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.690485e-02 | 1.772 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.690485e-02 | 1.772 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.982728e-02 | 1.703 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.982728e-02 | 1.703 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.982728e-02 | 1.703 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.982728e-02 | 1.703 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.982728e-02 | 1.703 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.982728e-02 | 1.703 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.710945e-02 | 1.767 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.834875e-02 | 1.736 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 1.834875e-02 | 1.736 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.762789e-02 | 1.754 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.762789e-02 | 1.754 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.762789e-02 | 1.754 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.197431e-02 | 1.658 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 2.197431e-02 | 1.658 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 1.947912e-02 | 1.710 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.947912e-02 | 1.710 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.704236e-02 | 1.768 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.990330e-02 | 1.701 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.730498e-02 | 1.762 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.956162e-02 | 1.709 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.934683e-02 | 1.713 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.213806e-02 | 1.655 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.203056e-02 | 1.657 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 1.990330e-02 | 1.701 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 2.007667e-02 | 1.697 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.990330e-02 | 1.701 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.762789e-02 | 1.754 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.782237e-02 | 1.749 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 1.762789e-02 | 1.754 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.990330e-02 | 1.701 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.990330e-02 | 1.701 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.747848e-02 | 1.757 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.990330e-02 | 1.701 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.953242e-02 | 1.709 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.211042e-02 | 1.655 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.947912e-02 | 1.710 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.089142e-02 | 1.680 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 2.258539e-02 | 1.646 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.174678e-02 | 1.663 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.947912e-02 | 1.710 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.934683e-02 | 1.713 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.880179e-02 | 1.726 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.730498e-02 | 1.762 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.764003e-02 | 1.754 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.956162e-02 | 1.709 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.704236e-02 | 1.768 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.277898e-02 | 1.642 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.277898e-02 | 1.642 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.340593e-02 | 1.631 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.345241e-02 | 1.630 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.345241e-02 | 1.630 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 2.345408e-02 | 1.630 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 2.364999e-02 | 1.626 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 2.379271e-02 | 1.624 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.379271e-02 | 1.624 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.663781e-02 | 1.575 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.663781e-02 | 1.575 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 2.699050e-02 | 1.569 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.735836e-02 | 1.563 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.735836e-02 | 1.563 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 2.764733e-02 | 1.558 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.764733e-02 | 1.558 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 2.764733e-02 | 1.558 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 2.764772e-02 | 1.558 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.795079e-02 | 1.554 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.795079e-02 | 1.554 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.795079e-02 | 1.554 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.816509e-02 | 1.550 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.830788e-02 | 1.548 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.831201e-02 | 1.548 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 2.869317e-02 | 1.542 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 2.869317e-02 | 1.542 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 3.018101e-02 | 1.520 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.018101e-02 | 1.520 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.037221e-02 | 1.518 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 3.081631e-02 | 1.511 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.090956e-02 | 1.510 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.122648e-02 | 1.505 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.164064e-02 | 1.500 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 3.164064e-02 | 1.500 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 3.164064e-02 | 1.500 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 3.164064e-02 | 1.500 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.164064e-02 | 1.500 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 3.180240e-02 | 1.498 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.245916e-02 | 1.489 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.245916e-02 | 1.489 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 3.362816e-02 | 1.473 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.375373e-02 | 1.472 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 3.392952e-02 | 1.469 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 3.423783e-02 | 1.465 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.423783e-02 | 1.465 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.429733e-02 | 1.465 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.442628e-02 | 1.463 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.483824e-02 | 1.458 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 3.612628e-02 | 1.442 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.655888e-02 | 1.437 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 3.655888e-02 | 1.437 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 3.655888e-02 | 1.437 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.655888e-02 | 1.437 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.699510e-02 | 1.432 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.699510e-02 | 1.432 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.727719e-02 | 1.429 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 3.755365e-02 | 1.425 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 3.755365e-02 | 1.425 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 3.755365e-02 | 1.425 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.790548e-02 | 1.421 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 3.792135e-02 | 1.421 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 3.862368e-02 | 1.413 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 3.874682e-02 | 1.412 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.886513e-02 | 1.410 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.916515e-02 | 1.407 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 3.916515e-02 | 1.407 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.916515e-02 | 1.407 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.916515e-02 | 1.407 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.952701e-02 | 1.403 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 3.952701e-02 | 1.403 | 0 | 0 |
| IRS activation | R-HSA-74713 | 4.022021e-02 | 1.396 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 4.024497e-02 | 1.395 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 4.100412e-02 | 1.387 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 4.161352e-02 | 1.381 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.560850e-02 | 1.255 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.560850e-02 | 1.255 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.560850e-02 | 1.255 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 4.593810e-02 | 1.338 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 4.593810e-02 | 1.338 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 5.534943e-02 | 1.257 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.534943e-02 | 1.257 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.534943e-02 | 1.257 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 5.435575e-02 | 1.265 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 5.910856e-02 | 1.228 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 5.910856e-02 | 1.228 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 4.580558e-02 | 1.339 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 4.175260e-02 | 1.379 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 4.269362e-02 | 1.370 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 5.910856e-02 | 1.228 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 4.593810e-02 | 1.338 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 4.480942e-02 | 1.349 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.876753e-02 | 1.312 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.296210e-02 | 1.276 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 5.246108e-02 | 1.280 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.534943e-02 | 1.257 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.910856e-02 | 1.228 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.162719e-02 | 1.381 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.560850e-02 | 1.255 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 5.246108e-02 | 1.280 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 5.464713e-02 | 1.262 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.534943e-02 | 1.257 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.914833e-02 | 1.228 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 4.480942e-02 | 1.349 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 5.097275e-02 | 1.293 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 4.161352e-02 | 1.381 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.753076e-02 | 1.323 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 4.479250e-02 | 1.349 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 4.876753e-02 | 1.312 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 4.637471e-02 | 1.334 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.622783e-02 | 1.335 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.622783e-02 | 1.335 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 4.989573e-02 | 1.302 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 4.649143e-02 | 1.333 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 4.989573e-02 | 1.302 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 4.989573e-02 | 1.302 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 4.407708e-02 | 1.356 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 4.130607e-02 | 1.384 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 5.622000e-02 | 1.250 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 4.147072e-02 | 1.382 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.483999e-02 | 1.348 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 4.130607e-02 | 1.384 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 4.559841e-02 | 1.341 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 4.130607e-02 | 1.384 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.610788e-02 | 1.336 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 5.246108e-02 | 1.280 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.534943e-02 | 1.257 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 5.722582e-02 | 1.242 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 6.154837e-02 | 1.211 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.560850e-02 | 1.255 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 6.171551e-02 | 1.210 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.239919e-02 | 1.205 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 6.243582e-02 | 1.205 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 6.243582e-02 | 1.205 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 6.243582e-02 | 1.205 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 6.311747e-02 | 1.200 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 6.311747e-02 | 1.200 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.311747e-02 | 1.200 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 6.575116e-02 | 1.182 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 6.579054e-02 | 1.182 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 6.579054e-02 | 1.182 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 6.579054e-02 | 1.182 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.642337e-02 | 1.178 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 6.717937e-02 | 1.173 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 6.717937e-02 | 1.173 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 6.717937e-02 | 1.173 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 6.717937e-02 | 1.173 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 6.755126e-02 | 1.170 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 6.874413e-02 | 1.163 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 6.897108e-02 | 1.161 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 6.905347e-02 | 1.161 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 6.905347e-02 | 1.161 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 6.905347e-02 | 1.161 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 6.932420e-02 | 1.159 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.266249e-02 | 1.139 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 7.337194e-02 | 1.134 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 7.432030e-02 | 1.129 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 7.588010e-02 | 1.120 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 7.588010e-02 | 1.120 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 7.588010e-02 | 1.120 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 7.660830e-02 | 1.116 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 7.660830e-02 | 1.116 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 7.691888e-02 | 1.114 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.691888e-02 | 1.114 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 7.691888e-02 | 1.114 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 7.691888e-02 | 1.114 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 7.691888e-02 | 1.114 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 7.725281e-02 | 1.112 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 7.725281e-02 | 1.112 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 7.725281e-02 | 1.112 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 7.725281e-02 | 1.112 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 7.915376e-02 | 1.102 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 8.025886e-02 | 1.096 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 8.050264e-02 | 1.094 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 8.069618e-02 | 1.093 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 8.085304e-02 | 1.092 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 8.085304e-02 | 1.092 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 8.298701e-02 | 1.081 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 8.404317e-02 | 1.075 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 8.404317e-02 | 1.075 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 8.404317e-02 | 1.075 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.427728e-02 | 1.074 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 8.434304e-02 | 1.074 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 8.434304e-02 | 1.074 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 8.434304e-02 | 1.074 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 8.434304e-02 | 1.074 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.472411e-02 | 1.072 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.472411e-02 | 1.072 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.520985e-02 | 1.070 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 8.520985e-02 | 1.070 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.539262e-02 | 1.069 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.539262e-02 | 1.069 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 8.971678e-02 | 1.047 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 8.971678e-02 | 1.047 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.971678e-02 | 1.047 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 9.002045e-02 | 1.046 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.002045e-02 | 1.046 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.069802e-02 | 1.042 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.069802e-02 | 1.042 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 9.104587e-02 | 1.041 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 9.252837e-02 | 1.034 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 9.252837e-02 | 1.034 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 9.297701e-02 | 1.032 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 9.331409e-02 | 1.030 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 9.331409e-02 | 1.030 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 9.331409e-02 | 1.030 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 9.331409e-02 | 1.030 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 9.408102e-02 | 1.026 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 9.439041e-02 | 1.025 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 9.439041e-02 | 1.025 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.439041e-02 | 1.025 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 9.439041e-02 | 1.025 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 9.439041e-02 | 1.025 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 9.439041e-02 | 1.025 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 9.459312e-02 | 1.024 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 9.459312e-02 | 1.024 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 9.459312e-02 | 1.024 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 9.459312e-02 | 1.024 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 9.459312e-02 | 1.024 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 9.459312e-02 | 1.024 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 9.516372e-02 | 1.022 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 9.551546e-02 | 1.020 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.750995e-02 | 1.011 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.766731e-02 | 1.010 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.790004e-02 | 1.009 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.799834e-02 | 1.009 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.891142e-02 | 1.005 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.954742e-02 | 1.002 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.954742e-02 | 1.002 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 9.955751e-02 | 1.002 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 1.001568e-01 | 0.999 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.007784e-01 | 0.997 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.007784e-01 | 0.997 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 1.007784e-01 | 0.997 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 1.007784e-01 | 0.997 | 0 | 0 |
| Drug resistance of FLT3 mutants | R-HSA-9702506 | 1.013645e-01 | 0.994 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 1.013645e-01 | 0.994 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 1.013645e-01 | 0.994 | 0 | 0 |
| FLT3 mutants bind TKIs | R-HSA-9702509 | 1.013645e-01 | 0.994 | 0 | 0 |
| quizartinib-resistant FLT3 mutants | R-HSA-9702620 | 1.013645e-01 | 0.994 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 1.013645e-01 | 0.994 | 0 | 0 |
| gilteritinib-resistant FLT3 mutants | R-HSA-9702590 | 1.013645e-01 | 0.994 | 0 | 0 |
| sorafenib-resistant FLT3 mutants | R-HSA-9702624 | 1.013645e-01 | 0.994 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 1.013645e-01 | 0.994 | 0 | 0 |
| ponatinib-resistant FLT3 mutants | R-HSA-9702614 | 1.013645e-01 | 0.994 | 0 | 0 |
| linifanib-resistant FLT3 mutants | R-HSA-9702998 | 1.013645e-01 | 0.994 | 0 | 0 |
| tandutinib-resistant FLT3 mutants | R-HSA-9702636 | 1.013645e-01 | 0.994 | 0 | 0 |
| pexidartinib-resistant FLT3 mutants | R-HSA-9702605 | 1.013645e-01 | 0.994 | 0 | 0 |
| KW2449-resistant FLT3 mutants | R-HSA-9702569 | 1.013645e-01 | 0.994 | 0 | 0 |
| sunitinib-resistant FLT3 mutants | R-HSA-9702632 | 1.013645e-01 | 0.994 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 1.013645e-01 | 0.994 | 0 | 0 |
| midostaurin-resistant FLT3 mutants | R-HSA-9702600 | 1.013645e-01 | 0.994 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 1.013645e-01 | 0.994 | 0 | 0 |
| semaxanib-resistant FLT3 mutants | R-HSA-9702577 | 1.013645e-01 | 0.994 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 1.013645e-01 | 0.994 | 0 | 0 |
| crenolanib-resistant FLT3 mutants | R-HSA-9702581 | 1.013645e-01 | 0.994 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 1.013645e-01 | 0.994 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 1.013645e-01 | 0.994 | 0 | 0 |
| lestaurtinib-resistant FLT3 mutants | R-HSA-9702596 | 1.013645e-01 | 0.994 | 0 | 0 |
| tamatinib-resistant FLT3 mutants | R-HSA-9703009 | 1.013645e-01 | 0.994 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.031531e-01 | 0.987 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.039076e-01 | 0.983 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 1.039076e-01 | 0.983 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 1.039076e-01 | 0.983 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.039263e-01 | 0.983 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.057330e-01 | 0.976 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 1.059286e-01 | 0.975 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.086886e-01 | 0.964 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.924597e-01 | 0.716 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 1.924597e-01 | 0.716 | 0 | 0 |
| Defective ACTH causes obesity and POMCD | R-HSA-5579031 | 1.924597e-01 | 0.716 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.924597e-01 | 0.716 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.924597e-01 | 0.716 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.924597e-01 | 0.716 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.924597e-01 | 0.716 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 1.356388e-01 | 0.868 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.356388e-01 | 0.868 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 1.356388e-01 | 0.868 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.356388e-01 | 0.868 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.726738e-01 | 0.763 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 1.726738e-01 | 0.763 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.726738e-01 | 0.763 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.152091e-01 | 0.939 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 1.152091e-01 | 0.939 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.388142e-01 | 0.858 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 1.388142e-01 | 0.858 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.110851e-01 | 0.676 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 2.110851e-01 | 0.676 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 1.113320e-01 | 0.953 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.483380e-01 | 0.829 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 1.175235e-01 | 0.930 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.175235e-01 | 0.930 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.683963e-01 | 0.774 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 2.173996e-01 | 0.663 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.173996e-01 | 0.663 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 1.488753e-01 | 0.827 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 1.893418e-01 | 0.723 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.893418e-01 | 0.723 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 1.893418e-01 | 0.723 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 1.457545e-01 | 0.836 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.110577e-01 | 0.676 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.833287e-01 | 0.737 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.833287e-01 | 0.737 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 1.603545e-01 | 0.795 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 1.603545e-01 | 0.795 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.244689e-01 | 0.905 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 2.015589e-01 | 0.696 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 2.015589e-01 | 0.696 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 1.755556e-01 | 0.756 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.538633e-01 | 0.813 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.354909e-01 | 0.868 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.354909e-01 | 0.868 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 1.354909e-01 | 0.868 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.354909e-01 | 0.868 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.354909e-01 | 0.868 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.400747e-01 | 0.854 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 1.589450e-01 | 0.799 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 1.589450e-01 | 0.799 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 1.589450e-01 | 0.799 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.430865e-01 | 0.844 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 1.204527e-01 | 0.919 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.204527e-01 | 0.919 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 1.841582e-01 | 0.735 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 2.109597e-01 | 0.676 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 1.305805e-01 | 0.884 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.741622e-01 | 0.759 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.169051e-01 | 0.932 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 2.122948e-01 | 0.673 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.841582e-01 | 0.735 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.683963e-01 | 0.774 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.508537e-01 | 0.821 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.913159e-01 | 0.718 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 1.102407e-01 | 0.958 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 1.538633e-01 | 0.813 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.102407e-01 | 0.958 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 1.913159e-01 | 0.718 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.755556e-01 | 0.756 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 1.726738e-01 | 0.763 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.169051e-01 | 0.932 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.379975e-01 | 0.860 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.388142e-01 | 0.858 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 1.538633e-01 | 0.813 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 1.197577e-01 | 0.922 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.113320e-01 | 0.953 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.483380e-01 | 0.829 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.893418e-01 | 0.723 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 2.109597e-01 | 0.676 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.893418e-01 | 0.723 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 2.173996e-01 | 0.663 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.942988e-01 | 0.712 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.672560e-01 | 0.777 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.087385e-01 | 0.964 | 0 | 0 |
| Activation and oligomerization of BAK protein | R-HSA-111452 | 1.924597e-01 | 0.716 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 1.356388e-01 | 0.868 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 1.356388e-01 | 0.868 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 1.726738e-01 | 0.763 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 2.173996e-01 | 0.663 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.286642e-01 | 0.891 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.913159e-01 | 0.718 | 0 | 0 |
| Translation | R-HSA-72766 | 1.400011e-01 | 0.854 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.327818e-01 | 0.877 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 1.718252e-01 | 0.765 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.977887e-01 | 0.704 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.124517e-01 | 0.949 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.442618e-01 | 0.841 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.292804e-01 | 0.888 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.942988e-01 | 0.712 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.532379e-01 | 0.815 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.638795e-01 | 0.785 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 1.197577e-01 | 0.922 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.688666e-01 | 0.772 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.130498e-01 | 0.947 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.550601e-01 | 0.809 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 1.924597e-01 | 0.716 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.924597e-01 | 0.716 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.356388e-01 | 0.868 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 1.488753e-01 | 0.827 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 2.110577e-01 | 0.676 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 1.538633e-01 | 0.813 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.286642e-01 | 0.891 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.496448e-01 | 0.825 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.483380e-01 | 0.829 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 1.175235e-01 | 0.930 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.388142e-01 | 0.858 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 1.893418e-01 | 0.723 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.317941e-01 | 0.880 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.603545e-01 | 0.795 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.755556e-01 | 0.756 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.204527e-01 | 0.919 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 1.841004e-01 | 0.735 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.973721e-01 | 0.705 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.973721e-01 | 0.705 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 2.102707e-01 | 0.677 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 2.102707e-01 | 0.677 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.954903e-01 | 0.709 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.154368e-01 | 0.667 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.097671e-01 | 0.960 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.109597e-01 | 0.676 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 1.726738e-01 | 0.763 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 1.603545e-01 | 0.795 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.292804e-01 | 0.888 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 1.139948e-01 | 0.943 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.286642e-01 | 0.891 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.672560e-01 | 0.777 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 2.075425e-01 | 0.683 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 1.388142e-01 | 0.858 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.657453e-01 | 0.781 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.532379e-01 | 0.815 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.973721e-01 | 0.705 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 1.657453e-01 | 0.781 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 1.457545e-01 | 0.836 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.893418e-01 | 0.723 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.823657e-01 | 0.739 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.755556e-01 | 0.756 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.657453e-01 | 0.781 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.307238e-01 | 0.884 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.683963e-01 | 0.774 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 2.110577e-01 | 0.676 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 1.726738e-01 | 0.763 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 2.204172e-01 | 0.657 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.243353e-01 | 0.649 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.248962e-01 | 0.648 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 2.254495e-01 | 0.647 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.254495e-01 | 0.647 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.263549e-01 | 0.645 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.288837e-01 | 0.640 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 2.299682e-01 | 0.638 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 2.334266e-01 | 0.632 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.334266e-01 | 0.632 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.334266e-01 | 0.632 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 2.409922e-01 | 0.618 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 2.415004e-01 | 0.617 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.415004e-01 | 0.617 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.415004e-01 | 0.617 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.415004e-01 | 0.617 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 2.415004e-01 | 0.617 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 2.453786e-01 | 0.610 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 2.453786e-01 | 0.610 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 2.453786e-01 | 0.610 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.500011e-01 | 0.602 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 2.502136e-01 | 0.602 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.502136e-01 | 0.602 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 2.502136e-01 | 0.602 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 2.502136e-01 | 0.602 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.502136e-01 | 0.602 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.502136e-01 | 0.602 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 2.502136e-01 | 0.602 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 2.502136e-01 | 0.602 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.502136e-01 | 0.602 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 2.515871e-01 | 0.599 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 2.537106e-01 | 0.596 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 2.563316e-01 | 0.591 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.563316e-01 | 0.591 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.563316e-01 | 0.591 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.594306e-01 | 0.586 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.600195e-01 | 0.585 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.730269e-01 | 0.564 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 2.730269e-01 | 0.564 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 2.738736e-01 | 0.562 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.738736e-01 | 0.562 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 2.743252e-01 | 0.562 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 2.743252e-01 | 0.562 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.743252e-01 | 0.562 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 2.743252e-01 | 0.562 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.743252e-01 | 0.562 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 2.743252e-01 | 0.562 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 2.743252e-01 | 0.562 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.743252e-01 | 0.562 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.743252e-01 | 0.562 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.743252e-01 | 0.562 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.743252e-01 | 0.562 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 2.743252e-01 | 0.562 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.743252e-01 | 0.562 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.743252e-01 | 0.562 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.743252e-01 | 0.562 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 2.768978e-01 | 0.558 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.768978e-01 | 0.558 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 2.768978e-01 | 0.558 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 2.795437e-01 | 0.554 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.795437e-01 | 0.554 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 2.795437e-01 | 0.554 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.796583e-01 | 0.553 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.796583e-01 | 0.553 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.796583e-01 | 0.553 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.796583e-01 | 0.553 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.796583e-01 | 0.553 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.796583e-01 | 0.553 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 2.796583e-01 | 0.553 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.815891e-01 | 0.550 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.895196e-01 | 0.538 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 2.895196e-01 | 0.538 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.895196e-01 | 0.538 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 2.895196e-01 | 0.538 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.895196e-01 | 0.538 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 2.895196e-01 | 0.538 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.895196e-01 | 0.538 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 2.895196e-01 | 0.538 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.925674e-01 | 0.534 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.925674e-01 | 0.534 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.939169e-01 | 0.532 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 2.950313e-01 | 0.530 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.959966e-01 | 0.529 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 2.988715e-01 | 0.525 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.999493e-01 | 0.523 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 3.026811e-01 | 0.519 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 3.032958e-01 | 0.518 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 3.032958e-01 | 0.518 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.032958e-01 | 0.518 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 3.060838e-01 | 0.514 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.061774e-01 | 0.514 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.061774e-01 | 0.514 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.061774e-01 | 0.514 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.061774e-01 | 0.514 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.061774e-01 | 0.514 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 3.166480e-01 | 0.499 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 3.204709e-01 | 0.494 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.205781e-01 | 0.494 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.205781e-01 | 0.494 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.206716e-01 | 0.494 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 3.206716e-01 | 0.494 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.232052e-01 | 0.491 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 3.271377e-01 | 0.485 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.271377e-01 | 0.485 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 3.285652e-01 | 0.483 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.285652e-01 | 0.483 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.285652e-01 | 0.483 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 3.285652e-01 | 0.483 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.285652e-01 | 0.483 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.285652e-01 | 0.483 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.285652e-01 | 0.483 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 3.299392e-01 | 0.482 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 3.316145e-01 | 0.479 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 3.316145e-01 | 0.479 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.398686e-01 | 0.469 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 3.427638e-01 | 0.465 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 3.427638e-01 | 0.465 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.478959e-01 | 0.459 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.478959e-01 | 0.459 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 3.478959e-01 | 0.459 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.478959e-01 | 0.459 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 3.478959e-01 | 0.459 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 3.478959e-01 | 0.459 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.478959e-01 | 0.459 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.478959e-01 | 0.459 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.510831e-01 | 0.455 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 3.533773e-01 | 0.452 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 3.569430e-01 | 0.447 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.585133e-01 | 0.445 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 3.605044e-01 | 0.443 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.629782e-01 | 0.440 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.669997e-01 | 0.435 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.669997e-01 | 0.435 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 3.669997e-01 | 0.435 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 3.669997e-01 | 0.435 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 3.669997e-01 | 0.435 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.669997e-01 | 0.435 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.669997e-01 | 0.435 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.669997e-01 | 0.435 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.669997e-01 | 0.435 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.669997e-01 | 0.435 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 3.669997e-01 | 0.435 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.669997e-01 | 0.435 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.693222e-01 | 0.433 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 3.693222e-01 | 0.433 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 3.693222e-01 | 0.433 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.750370e-01 | 0.426 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.750370e-01 | 0.426 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 3.814120e-01 | 0.419 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.833613e-01 | 0.416 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 3.837577e-01 | 0.416 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.880986e-01 | 0.411 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.880986e-01 | 0.411 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.880986e-01 | 0.411 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 3.880986e-01 | 0.411 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 3.880986e-01 | 0.411 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 3.880986e-01 | 0.411 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 3.891993e-01 | 0.410 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 3.891993e-01 | 0.410 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.891993e-01 | 0.410 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 3.933498e-01 | 0.405 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 3.951143e-01 | 0.403 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 3.981996e-01 | 0.400 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 3.989107e-01 | 0.399 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.989107e-01 | 0.399 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 3.989107e-01 | 0.399 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 3.989107e-01 | 0.399 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 4.033935e-01 | 0.394 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 4.040070e-01 | 0.394 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 4.045458e-01 | 0.393 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 4.045458e-01 | 0.393 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.045458e-01 | 0.393 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 4.045458e-01 | 0.393 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 4.045458e-01 | 0.393 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.045458e-01 | 0.393 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.045458e-01 | 0.393 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 4.045458e-01 | 0.393 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 4.045458e-01 | 0.393 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.045458e-01 | 0.393 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.045458e-01 | 0.393 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.068671e-01 | 0.391 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 4.068671e-01 | 0.391 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 4.096332e-01 | 0.388 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 4.134175e-01 | 0.384 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.140117e-01 | 0.383 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 4.140117e-01 | 0.383 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.140117e-01 | 0.383 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 4.140117e-01 | 0.383 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 4.140117e-01 | 0.383 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 4.140117e-01 | 0.383 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.140117e-01 | 0.383 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.140117e-01 | 0.383 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 4.140117e-01 | 0.383 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 4.175646e-01 | 0.379 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 4.175646e-01 | 0.379 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 4.175646e-01 | 0.379 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 4.175646e-01 | 0.379 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 4.175646e-01 | 0.379 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 4.226226e-01 | 0.374 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 4.226226e-01 | 0.374 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 4.226226e-01 | 0.374 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 4.234600e-01 | 0.373 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 4.237307e-01 | 0.373 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.252498e-01 | 0.371 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 4.292475e-01 | 0.367 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.395067e-01 | 0.357 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.409887e-01 | 0.356 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.409887e-01 | 0.356 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 4.409887e-01 | 0.356 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 4.409887e-01 | 0.356 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.409887e-01 | 0.356 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.409887e-01 | 0.356 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 4.409887e-01 | 0.356 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 4.454276e-01 | 0.351 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 4.454829e-01 | 0.351 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 4.454829e-01 | 0.351 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 4.454829e-01 | 0.351 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.460976e-01 | 0.351 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 4.460976e-01 | 0.351 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 4.460976e-01 | 0.351 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 4.460976e-01 | 0.351 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 4.573462e-01 | 0.340 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.627185e-01 | 0.335 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.692678e-01 | 0.329 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.692678e-01 | 0.329 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 4.704600e-01 | 0.327 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 4.727617e-01 | 0.325 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 4.728524e-01 | 0.325 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 4.728524e-01 | 0.325 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 4.728524e-01 | 0.325 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 4.728524e-01 | 0.325 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.734276e-01 | 0.325 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.734276e-01 | 0.325 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 4.734276e-01 | 0.325 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 4.734276e-01 | 0.325 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.734276e-01 | 0.325 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.734276e-01 | 0.325 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.734276e-01 | 0.325 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.734276e-01 | 0.325 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 4.734276e-01 | 0.325 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.734276e-01 | 0.325 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.734276e-01 | 0.325 | 0 | 0 |
| Toxicity of tetanus toxin (tetX) | R-HSA-5250982 | 4.734276e-01 | 0.325 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.761662e-01 | 0.322 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.761662e-01 | 0.322 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 4.761662e-01 | 0.322 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 4.761662e-01 | 0.322 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.761662e-01 | 0.322 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.761662e-01 | 0.322 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 4.778761e-01 | 0.321 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 4.806632e-01 | 0.318 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 4.810594e-01 | 0.318 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 4.854236e-01 | 0.314 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 4.860907e-01 | 0.313 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 4.860907e-01 | 0.313 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 4.920721e-01 | 0.308 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 4.920721e-01 | 0.308 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 4.973940e-01 | 0.303 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.992054e-01 | 0.302 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.992054e-01 | 0.302 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.992054e-01 | 0.302 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 4.995866e-01 | 0.301 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 4.995866e-01 | 0.301 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 5.060270e-01 | 0.296 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.099604e-01 | 0.292 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.099604e-01 | 0.292 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.099604e-01 | 0.292 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 5.099604e-01 | 0.292 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 5.099604e-01 | 0.292 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 5.099604e-01 | 0.292 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 5.099604e-01 | 0.292 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 5.099604e-01 | 0.292 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 5.099604e-01 | 0.292 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 5.099604e-01 | 0.292 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 5.256133e-01 | 0.279 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 5.256133e-01 | 0.279 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 5.256133e-01 | 0.279 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 5.256133e-01 | 0.279 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.256481e-01 | 0.279 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 5.256481e-01 | 0.279 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 5.268222e-01 | 0.278 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.268222e-01 | 0.278 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.268222e-01 | 0.278 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 5.268222e-01 | 0.278 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 5.268222e-01 | 0.278 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.268222e-01 | 0.278 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 5.268222e-01 | 0.278 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.268222e-01 | 0.278 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.268222e-01 | 0.278 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.268222e-01 | 0.278 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 5.268222e-01 | 0.278 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.268222e-01 | 0.278 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.268222e-01 | 0.278 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.268222e-01 | 0.278 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 5.268222e-01 | 0.278 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 5.353492e-01 | 0.271 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.363723e-01 | 0.271 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.422901e-01 | 0.266 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 5.422901e-01 | 0.266 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 5.422901e-01 | 0.266 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.422901e-01 | 0.266 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 5.422901e-01 | 0.266 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 5.449200e-01 | 0.264 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 5.449200e-01 | 0.264 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 5.449200e-01 | 0.264 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 5.483995e-01 | 0.261 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 5.508730e-01 | 0.259 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 5.521798e-01 | 0.258 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.573906e-01 | 0.254 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.575559e-01 | 0.254 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 5.577790e-01 | 0.254 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 5.643632e-01 | 0.248 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 5.696703e-01 | 0.244 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.731049e-01 | 0.242 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 5.731049e-01 | 0.242 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.742847e-01 | 0.241 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 5.742847e-01 | 0.241 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 5.748054e-01 | 0.240 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.748054e-01 | 0.240 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.748054e-01 | 0.240 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.748054e-01 | 0.240 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.748054e-01 | 0.240 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 5.748054e-01 | 0.240 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 5.748054e-01 | 0.240 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.748054e-01 | 0.240 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.748054e-01 | 0.240 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.748054e-01 | 0.240 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 5.748054e-01 | 0.240 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.748054e-01 | 0.240 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 5.748054e-01 | 0.240 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 5.748054e-01 | 0.240 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.748054e-01 | 0.240 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 5.748054e-01 | 0.240 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 5.753183e-01 | 0.240 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 5.753183e-01 | 0.240 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 5.753183e-01 | 0.240 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 5.753183e-01 | 0.240 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 5.753183e-01 | 0.240 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 5.753183e-01 | 0.240 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 5.763631e-01 | 0.239 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 5.786410e-01 | 0.238 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 5.860240e-01 | 0.232 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 5.875393e-01 | 0.231 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 5.933373e-01 | 0.227 | 0 | 0 |
| Immune System | R-HSA-168256 | 5.980020e-01 | 0.223 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 5.989129e-01 | 0.223 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 5.989129e-01 | 0.223 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 5.989287e-01 | 0.223 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.003528e-01 | 0.222 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 6.023796e-01 | 0.220 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 6.023796e-01 | 0.220 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 6.023796e-01 | 0.220 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.023796e-01 | 0.220 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.023796e-01 | 0.220 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 6.023796e-01 | 0.220 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.024411e-01 | 0.220 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 6.059448e-01 | 0.218 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.101474e-01 | 0.215 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.155863e-01 | 0.211 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 6.179254e-01 | 0.209 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.179254e-01 | 0.209 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 6.179254e-01 | 0.209 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 6.179254e-01 | 0.209 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.179254e-01 | 0.209 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 6.179254e-01 | 0.209 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.179254e-01 | 0.209 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 6.179254e-01 | 0.209 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 6.179254e-01 | 0.209 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 6.179254e-01 | 0.209 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.179254e-01 | 0.209 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 6.179254e-01 | 0.209 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 6.179254e-01 | 0.209 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 6.179254e-01 | 0.209 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 6.179580e-01 | 0.209 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.184987e-01 | 0.209 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 6.186177e-01 | 0.209 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 6.186177e-01 | 0.209 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 6.186177e-01 | 0.209 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 6.186177e-01 | 0.209 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 6.197151e-01 | 0.208 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 6.197151e-01 | 0.208 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 6.216301e-01 | 0.206 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 6.216301e-01 | 0.206 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.301096e-01 | 0.201 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.301096e-01 | 0.201 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 6.301096e-01 | 0.201 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 6.301096e-01 | 0.201 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 6.301096e-01 | 0.201 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.301096e-01 | 0.201 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 6.301096e-01 | 0.201 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 6.301096e-01 | 0.201 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 6.360300e-01 | 0.197 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 6.376890e-01 | 0.195 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 6.434522e-01 | 0.191 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 6.434522e-01 | 0.191 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 6.434522e-01 | 0.191 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 6.434522e-01 | 0.191 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.484687e-01 | 0.188 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 6.493388e-01 | 0.188 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 6.517534e-01 | 0.186 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 6.563071e-01 | 0.183 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.563071e-01 | 0.183 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.566747e-01 | 0.183 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.566747e-01 | 0.183 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 6.566747e-01 | 0.183 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 6.566747e-01 | 0.183 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.566747e-01 | 0.183 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 6.566747e-01 | 0.183 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.566747e-01 | 0.183 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.566747e-01 | 0.183 | 0 | 0 |
| Opsins | R-HSA-419771 | 6.566747e-01 | 0.183 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.566747e-01 | 0.183 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 6.566747e-01 | 0.183 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 6.566747e-01 | 0.183 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.566747e-01 | 0.183 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 6.566747e-01 | 0.183 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 6.566747e-01 | 0.183 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.577220e-01 | 0.182 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 6.624884e-01 | 0.179 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 6.631801e-01 | 0.178 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 6.643693e-01 | 0.178 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 6.643693e-01 | 0.178 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 6.679187e-01 | 0.175 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 6.788770e-01 | 0.168 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.809977e-01 | 0.167 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.809977e-01 | 0.167 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.809977e-01 | 0.167 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 6.809977e-01 | 0.167 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.835837e-01 | 0.165 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.835837e-01 | 0.165 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 6.843782e-01 | 0.165 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 6.843782e-01 | 0.165 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 6.843782e-01 | 0.165 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 6.865207e-01 | 0.163 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 6.914962e-01 | 0.160 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 6.914962e-01 | 0.160 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.914962e-01 | 0.160 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.914962e-01 | 0.160 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 6.914962e-01 | 0.160 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.914962e-01 | 0.160 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.914962e-01 | 0.160 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 6.914962e-01 | 0.160 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 6.914962e-01 | 0.160 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 6.914962e-01 | 0.160 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.914962e-01 | 0.160 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 6.914962e-01 | 0.160 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.914962e-01 | 0.160 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 6.914962e-01 | 0.160 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.929616e-01 | 0.159 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 6.938622e-01 | 0.159 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 6.938622e-01 | 0.159 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 6.938622e-01 | 0.159 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 6.986737e-01 | 0.156 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.023639e-01 | 0.153 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 7.034822e-01 | 0.153 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 7.042176e-01 | 0.152 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 7.042176e-01 | 0.152 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 7.042176e-01 | 0.152 | 0 | 0 |
| PKA activation | R-HSA-163615 | 7.042176e-01 | 0.152 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 7.042176e-01 | 0.152 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 7.042176e-01 | 0.152 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 7.042176e-01 | 0.152 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 7.042176e-01 | 0.152 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 7.066299e-01 | 0.151 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 7.075689e-01 | 0.150 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 7.096373e-01 | 0.149 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 7.110188e-01 | 0.148 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.133920e-01 | 0.147 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.143393e-01 | 0.146 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 7.216895e-01 | 0.142 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 7.227878e-01 | 0.141 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 7.227878e-01 | 0.141 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.227878e-01 | 0.141 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 7.227878e-01 | 0.141 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.227878e-01 | 0.141 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.227878e-01 | 0.141 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.227878e-01 | 0.141 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 7.227878e-01 | 0.141 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.227878e-01 | 0.141 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 7.234146e-01 | 0.141 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 7.260110e-01 | 0.139 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 7.260110e-01 | 0.139 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 7.260110e-01 | 0.139 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 7.260110e-01 | 0.139 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 7.260110e-01 | 0.139 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 7.349116e-01 | 0.134 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 7.383564e-01 | 0.132 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 7.390129e-01 | 0.131 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 7.390129e-01 | 0.131 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.390129e-01 | 0.131 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.390129e-01 | 0.131 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.410411e-01 | 0.130 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 7.411586e-01 | 0.130 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.451120e-01 | 0.128 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 7.451120e-01 | 0.128 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 7.464283e-01 | 0.127 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 7.464283e-01 | 0.127 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.464283e-01 | 0.127 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 7.497746e-01 | 0.125 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.509072e-01 | 0.124 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 7.509072e-01 | 0.124 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.509072e-01 | 0.124 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 7.509072e-01 | 0.124 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.509072e-01 | 0.124 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.509072e-01 | 0.124 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.509072e-01 | 0.124 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 7.531705e-01 | 0.123 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.655245e-01 | 0.116 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 7.655245e-01 | 0.116 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 7.655245e-01 | 0.116 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.655245e-01 | 0.116 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 7.655245e-01 | 0.116 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.655245e-01 | 0.116 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 7.668954e-01 | 0.115 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 7.686641e-01 | 0.114 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.710778e-01 | 0.113 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 7.761757e-01 | 0.110 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 7.761757e-01 | 0.110 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 7.761757e-01 | 0.110 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 7.761757e-01 | 0.110 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.761757e-01 | 0.110 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 7.761757e-01 | 0.110 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.761757e-01 | 0.110 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.761757e-01 | 0.110 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 7.761757e-01 | 0.110 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.761757e-01 | 0.110 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.761757e-01 | 0.110 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.761757e-01 | 0.110 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.798159e-01 | 0.108 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.833574e-01 | 0.106 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 7.833574e-01 | 0.106 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 7.858616e-01 | 0.105 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.905569e-01 | 0.102 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.928258e-01 | 0.101 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 7.930715e-01 | 0.101 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 7.937146e-01 | 0.100 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.988822e-01 | 0.098 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.988822e-01 | 0.098 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 7.988822e-01 | 0.098 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.988822e-01 | 0.098 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 7.988822e-01 | 0.098 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 7.988822e-01 | 0.098 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 7.988822e-01 | 0.098 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.988822e-01 | 0.098 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.988822e-01 | 0.098 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.998452e-01 | 0.097 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 7.998452e-01 | 0.097 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.998452e-01 | 0.097 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.999868e-01 | 0.097 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.999868e-01 | 0.097 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 8.017845e-01 | 0.096 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 8.030985e-01 | 0.095 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.051856e-01 | 0.094 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.124540e-01 | 0.090 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.130548e-01 | 0.090 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.130548e-01 | 0.090 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 8.154732e-01 | 0.089 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.166999e-01 | 0.088 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.166999e-01 | 0.088 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 8.173139e-01 | 0.088 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.192864e-01 | 0.087 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 8.192864e-01 | 0.087 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 8.192864e-01 | 0.087 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.192864e-01 | 0.087 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 8.192864e-01 | 0.087 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.192864e-01 | 0.087 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.192864e-01 | 0.087 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.192864e-01 | 0.087 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 8.192864e-01 | 0.087 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 8.192864e-01 | 0.087 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.192864e-01 | 0.087 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 8.192864e-01 | 0.087 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.192864e-01 | 0.087 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.192864e-01 | 0.087 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 8.192864e-01 | 0.087 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.192864e-01 | 0.087 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.192864e-01 | 0.087 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.192864e-01 | 0.087 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.197729e-01 | 0.086 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.215356e-01 | 0.085 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.284266e-01 | 0.082 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 8.298773e-01 | 0.081 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 8.298773e-01 | 0.081 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 8.298773e-01 | 0.081 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.298773e-01 | 0.081 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.324112e-01 | 0.080 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 8.366928e-01 | 0.077 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.372629e-01 | 0.077 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.372629e-01 | 0.077 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.372629e-01 | 0.077 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 8.376216e-01 | 0.077 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 8.376216e-01 | 0.077 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 8.376216e-01 | 0.077 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 8.376216e-01 | 0.077 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.376216e-01 | 0.077 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.376216e-01 | 0.077 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.376216e-01 | 0.077 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 8.376216e-01 | 0.077 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.380485e-01 | 0.077 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 8.432594e-01 | 0.074 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 8.432594e-01 | 0.074 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 8.432594e-01 | 0.074 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.432594e-01 | 0.074 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 8.432594e-01 | 0.074 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.506007e-01 | 0.070 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.511414e-01 | 0.070 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 8.511414e-01 | 0.070 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.540975e-01 | 0.068 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 8.540975e-01 | 0.068 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.540975e-01 | 0.068 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.540975e-01 | 0.068 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.540975e-01 | 0.068 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.540975e-01 | 0.068 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.540975e-01 | 0.068 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.540975e-01 | 0.068 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.540975e-01 | 0.068 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.547525e-01 | 0.068 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.547525e-01 | 0.068 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.547525e-01 | 0.068 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.556784e-01 | 0.068 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.587154e-01 | 0.066 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.587154e-01 | 0.066 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 8.649019e-01 | 0.063 | 0 | 0 |
| Disease | R-HSA-1643685 | 8.659746e-01 | 0.062 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.661327e-01 | 0.062 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 8.671196e-01 | 0.062 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.671196e-01 | 0.062 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.671919e-01 | 0.062 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 8.671919e-01 | 0.062 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.684816e-01 | 0.061 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.689025e-01 | 0.061 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.689025e-01 | 0.061 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.689025e-01 | 0.061 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 8.689025e-01 | 0.061 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.689025e-01 | 0.061 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.689025e-01 | 0.061 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 8.734773e-01 | 0.059 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.748649e-01 | 0.058 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.778559e-01 | 0.057 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 8.781100e-01 | 0.056 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 8.822061e-01 | 0.054 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.822061e-01 | 0.054 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.822061e-01 | 0.054 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 8.822061e-01 | 0.054 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.822061e-01 | 0.054 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 8.822061e-01 | 0.054 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.822061e-01 | 0.054 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.822061e-01 | 0.054 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.822061e-01 | 0.054 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.822061e-01 | 0.054 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.835865e-01 | 0.054 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.862402e-01 | 0.052 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.873670e-01 | 0.052 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 8.877241e-01 | 0.052 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 8.877241e-01 | 0.052 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.877241e-01 | 0.052 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 8.877241e-01 | 0.052 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.906459e-01 | 0.050 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.911171e-01 | 0.050 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 8.915919e-01 | 0.050 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 8.928433e-01 | 0.049 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 8.941602e-01 | 0.049 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 8.941602e-01 | 0.049 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.941602e-01 | 0.049 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 8.941602e-01 | 0.049 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 8.942901e-01 | 0.049 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.942901e-01 | 0.049 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.942901e-01 | 0.049 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.968481e-01 | 0.047 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.018243e-01 | 0.045 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 9.049019e-01 | 0.043 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 9.049019e-01 | 0.043 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.052774e-01 | 0.043 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 9.052774e-01 | 0.043 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.056308e-01 | 0.043 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 9.088702e-01 | 0.041 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.108477e-01 | 0.041 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.130589e-01 | 0.040 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.130589e-01 | 0.040 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.130589e-01 | 0.040 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.130589e-01 | 0.040 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.131754e-01 | 0.039 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 9.145540e-01 | 0.039 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 9.145540e-01 | 0.039 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.202372e-01 | 0.036 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.223718e-01 | 0.035 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.232269e-01 | 0.035 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.232269e-01 | 0.035 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.232269e-01 | 0.035 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 9.232269e-01 | 0.035 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.232269e-01 | 0.035 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.232269e-01 | 0.035 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.232269e-01 | 0.035 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.232269e-01 | 0.035 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.266429e-01 | 0.033 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.268547e-01 | 0.033 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.268547e-01 | 0.033 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.268888e-01 | 0.033 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.273380e-01 | 0.033 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.310200e-01 | 0.031 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.310200e-01 | 0.031 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.310200e-01 | 0.031 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.310200e-01 | 0.031 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.310200e-01 | 0.031 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.310200e-01 | 0.031 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.315576e-01 | 0.031 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.319255e-01 | 0.031 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.329511e-01 | 0.030 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.329511e-01 | 0.030 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.329511e-01 | 0.030 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.361725e-01 | 0.029 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.376696e-01 | 0.028 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 9.380224e-01 | 0.028 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.380224e-01 | 0.028 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.380224e-01 | 0.028 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.380224e-01 | 0.028 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.385640e-01 | 0.028 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.385640e-01 | 0.028 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.387048e-01 | 0.027 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.405030e-01 | 0.027 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.409650e-01 | 0.026 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.437288e-01 | 0.025 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.437288e-01 | 0.025 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 9.437288e-01 | 0.025 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.437288e-01 | 0.025 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.443144e-01 | 0.025 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 9.443144e-01 | 0.025 | 0 | 0 |
| Glucocorticoid biosynthesis | R-HSA-194002 | 9.443144e-01 | 0.025 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.443144e-01 | 0.025 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.443144e-01 | 0.025 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.484785e-01 | 0.023 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.484785e-01 | 0.023 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.499679e-01 | 0.022 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.499679e-01 | 0.022 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.499679e-01 | 0.022 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.499679e-01 | 0.022 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.506433e-01 | 0.022 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.528442e-01 | 0.021 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.528442e-01 | 0.021 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.550478e-01 | 0.020 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 9.556263e-01 | 0.020 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.580018e-01 | 0.019 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.596121e-01 | 0.018 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.605375e-01 | 0.017 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.631052e-01 | 0.016 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.631052e-01 | 0.016 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.637132e-01 | 0.016 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.637132e-01 | 0.016 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.637132e-01 | 0.016 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.637132e-01 | 0.016 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.637132e-01 | 0.016 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.637132e-01 | 0.016 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.640477e-01 | 0.016 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.670182e-01 | 0.015 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.673982e-01 | 0.014 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.673982e-01 | 0.014 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.673982e-01 | 0.014 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.673982e-01 | 0.014 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.673982e-01 | 0.014 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.673982e-01 | 0.014 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.698615e-01 | 0.013 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.698615e-01 | 0.013 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.698615e-01 | 0.013 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.698615e-01 | 0.013 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.698615e-01 | 0.013 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.707091e-01 | 0.013 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.707091e-01 | 0.013 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 9.707091e-01 | 0.013 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.707091e-01 | 0.013 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.724677e-01 | 0.012 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.726663e-01 | 0.012 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.732636e-01 | 0.012 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.736839e-01 | 0.012 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.736839e-01 | 0.012 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.736839e-01 | 0.012 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.736839e-01 | 0.012 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.736839e-01 | 0.012 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.738262e-01 | 0.012 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.739664e-01 | 0.011 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.739664e-01 | 0.011 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.739664e-01 | 0.011 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.748556e-01 | 0.011 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.748556e-01 | 0.011 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.760055e-01 | 0.011 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.763568e-01 | 0.010 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.763568e-01 | 0.010 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.763568e-01 | 0.010 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.778920e-01 | 0.010 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.787583e-01 | 0.009 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.787583e-01 | 0.009 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.787583e-01 | 0.009 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 9.790450e-01 | 0.009 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.802703e-01 | 0.009 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.808775e-01 | 0.008 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.809178e-01 | 0.008 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.819693e-01 | 0.008 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.819693e-01 | 0.008 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.819693e-01 | 0.008 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.840877e-01 | 0.007 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.840877e-01 | 0.007 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.845965e-01 | 0.007 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.854897e-01 | 0.006 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.861615e-01 | 0.006 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.861615e-01 | 0.006 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.862187e-01 | 0.006 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.862416e-01 | 0.006 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.865607e-01 | 0.006 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.867713e-01 | 0.006 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.875675e-01 | 0.005 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.875675e-01 | 0.005 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.875675e-01 | 0.005 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.875675e-01 | 0.005 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.876431e-01 | 0.005 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.888308e-01 | 0.005 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.888308e-01 | 0.005 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.888308e-01 | 0.005 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.888308e-01 | 0.005 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.890120e-01 | 0.005 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.893101e-01 | 0.005 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.895619e-01 | 0.005 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.899889e-01 | 0.004 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.909854e-01 | 0.004 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.909854e-01 | 0.004 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.909854e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.909854e-01 | 0.004 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.909854e-01 | 0.004 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.910024e-01 | 0.004 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.934641e-01 | 0.003 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.934641e-01 | 0.003 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.941285e-01 | 0.003 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.941285e-01 | 0.003 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.941285e-01 | 0.003 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.942972e-01 | 0.002 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.942972e-01 | 0.002 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.948111e-01 | 0.002 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.948111e-01 | 0.002 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.952078e-01 | 0.002 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.952078e-01 | 0.002 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.954624e-01 | 0.002 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.956184e-01 | 0.002 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.961760e-01 | 0.002 | 0 | 0 |
| The canonical retinoid cycle in rods (twilight vision) | R-HSA-2453902 | 9.965648e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.974194e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.975098e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.977976e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.979991e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.979991e-01 | 0.001 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.981950e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.982374e-01 | 0.001 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.983210e-01 | 0.001 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.983492e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.985008e-01 | 0.001 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.985670e-01 | 0.001 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.985670e-01 | 0.001 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.989443e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.989816e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.990115e-01 | 0.000 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.990518e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.990518e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.991812e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.992815e-01 | 0.000 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.992910e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.993128e-01 | 0.000 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.993128e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.993761e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.993998e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.995020e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.995527e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.995527e-01 | 0.000 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.996391e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.996759e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.996759e-01 | 0.000 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.996759e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.996759e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.997307e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.997651e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.997890e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.997890e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.997892e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.998034e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.998105e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.998106e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.998274e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.998472e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.998627e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.998699e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.998747e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.998784e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.998812e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999005e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999177e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999280e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999468e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999492e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999617e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999704e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999712e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999776e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999826e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999855e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999858e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999871e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999896e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999916e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999935e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999951e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999977e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999977e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999988e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999990e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999991e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999994e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999995e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999996e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999997e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999997e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999998e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999999e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |